UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 10-K
                        FOR ANNUAL AND TRANSITION REPORTS

                    PURSUANT TO SECTIONS 13 OR 15 (d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

(MARK ONE)

/X/      ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES 
         EXCHANGE ACT OF 1934 
         [FEE REQUIRED]

                   FOR THE FISCAL YEAR ENDED DECEMBER 31, 1998

                                       OR

/ /      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES 
         EXCHANGE ACT OF 1934 
         [NO FEE REQUIRED]

                        FOR THE TRANSITION PERIOD FROM TO
                         COMMISSION FILE NUMBER 0-21810

                                --------------------

                              AMERIGON INCORPORATED
             (Exact name of registrant as specified in its charter)

             CALIFORNIA                                        95-4318554
 -----------------------------------------------    ----------------------------
  (State or other jurisdiction of                         (I.R.S. Employer
   incorporation or organization)                        Identification No.)

 5462 IRWINDALE AVENUE, IRWINDALE, CALIFORNIA                  91706-2058
 -----------------------------------------------    -----------------------
   (Address of principal executive offices)                    (Zip Code)

       Registrant's telephone number, including area code: (626) 815-7400

Securities registered pursuant to Section 12(b) of the Act:  None

Securities registered pursuant to Section 12(g) of the Act:

                       Class A Common Stock, no par value
                       ----------------------------------
                                (Title of Class)

                                Class A Warrants
                       ----------------------------------
                                (Title of Class)

Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days. Yes /X/  No / /

Indicate by check mark if disclosure of delinquent filers pursuant to Item 
405 of Regulation S-K is not contained herein, and will not be contained, to 
the best of registrant's knowledge, in definitive proxy or information 
statements incorporated by reference in Part III of this Form 10-K or any 
amendment to this Form 10-K / /

The aggregate market value of the voting stock held by non-affiliates of the 
registrant, computed by reference to the average bid and asked prices of such 
stock as of February 26, 1999, was $2,711,469. (For purposes of this 
computation, the registrant has excluded the market value of all shares of 
its Common Stock reported as being beneficially owned by executive officers 
and directors of the registrant; such exclusion shall not be deemed to 
constitute an admission that any such person is an "affiliate" of the 
registrant.)

At February 26, 1999, the registrant had issued and outstanding 2,510,089 
shares of Class A Common Stock.

                      DOCUMENTS INCORPORATED BY REFERENCE.

Portions of the registrant's definitive proxy statement for its 1999 Annual 
Meeting of Shareholders to be filed with the Commission within 120 days after 
the close of the registrant's fiscal year are incorporated by reference into 
Part III.



                                    AMERIGON

ITEM 1.  BUSINESS

GENERAL

Amerigon Incorporated (the "Company") is a development stage company 
incorporated in California in 1991 to develop, manufacture and market 
proprietary high technology automotive components and systems for sale to 
automobile and other original equipment manufacturers. The Company was 
founded on the premise that technology proven for use in the defense and 
aerospace industries could be successfully adapted to the automotive and 
transportation industries. The Company is focused on technologies that it 
believes can be readily adapted to automotive needs for advanced vehicle 
electronics. The Company seeks to avoid direct competition with established 
automotive suppliers of commodity products by identifying market 
opportunities where the need for rapid technological change gives an edge to 
new market entrants with proprietary products. The Company is principally 
focused on developing proprietary positions in the following technologies: 
(i) thermoelectric heated and cooled seats; and (ii) radar for maneuvering 
and safety.

The Company is presently working with a number of the world's largest 
automotive original equipment manufacturers ("OEMs") and seat manufacturers 
on pre-production and production development programs for heated and cooled 
seats. In addition, the Company has sold many prototypes of its heated and 
cooled seats to potential customers for evaluation and demonstration. In 
December 1997, the Company received its first production order for its heated 
and cooled seat product but shipments of production units in 1998 were very 
small. During 1998, the Company was selected by Johnson Controls, a major 
seat supplier to automotive OEMs to supply its Climate Control Seat ("CCS") 
system to be installed in seat systems on one platform for a major North 
American auto manufacturer starting in the 2000 model year. The Company's 
radar for maneuvering and safety is in an earlier stage of development than 
the heated and cooled seats. The Company has developed prototypes of the 
radar product and sold them to various automotive and other companies.

FINANCIAL INFORMATION ABOUT INDUSTRY SEGMENTS

The Company's business segment information is incorporated herein by 
reference from Note 16 of the Company's financial statements and related 
financial information indexed on page F-1 of this report and incorporated by 
reference into this report.

PRODUCTS

CLIMATE CONTROL SEAT SYSTEM

The Company's CCS system utilizes an exclusive, licensed, patented 
technology, as well as two patents held by the Company, on a variable 
temperature seat climate control system to improve the temperature comfort of 
automobile passengers. The CCS uses one or more small thermoelectric modules, 
which are solid-state devices the surfaces of which turn hot or cold 
depending on the polarity of applied direct current electricity. 
Heat-transfer parts attached to the modules cool or heat air that is blown 
past them. The conditioned air is then circulated through ducts and pads in 
the seat so that the surface of the seat grows warm or cool for the 
passengers, with small quantities of conditioned air passing through the seat 
to flow directly on the passengers. Each seat has individual electronic 
controls to adjust the level of heating or cooling. The CCS uses 
substantially less energy than conventional air conditioners by focusing the 
cooling directly on the passengers through the seat, rather than cooling the 
entire ambient air volume and the interior surfaces of the vehicle.

The CCS product has reached the stage where it can be mass-produced for a 
particular customer. However, since each customer's seats are not the same, 
and therefore have different configuration requirements, the Company must 
tailor its product to meet those design criteria. A customer will provide the 
Company with one of its car seats to be modified so that a CCS unit may be 
installed as a prototype. The seat is then returned to the customer for 
evaluation and testing. The Company has delivered prototype units to most 
major automobile companies and/or seat manufacturers who sell seats to those 
companies. Once the prototype is approved, further development will take 
place to make the CCS product production-ready. The lengthy evaluation and 
design cycles required by the major OEMs will result in a lack of high-volume 
sales to these customers for approximately the next one to two years although 
the Company expects to begin production at relatively low volumes in the next 
twelve months. However, the Company has targeted non-OEM customers who can 
quickly "design in" the CCS products and has received its first production 
order from one of those customers and has delivered a very small 

                                       1



number of units in 1998. The Company continues to do additional research and 
development to modify the existing product with the goal of making the unit 
less complex, more energy efficient and less expensive to manufacture and 
install. There can be no assurance that these development programs will 
result in viable products or lead to commercial production orders.

Since Amerigon's CCS system provides both heating and cooling, the Company 
believes that the potential market for CCS is larger than the market for 
heated seats alone. The Company also believes that the CCS concept could be 
applied to seats other than those used in motor vehicles (e.g., to aircraft, 
theater, and stadium seating) although the Company has not devoted any 
resources to the development of such applications.

RADAR FOR MANEUVERING AND SAFETY

In January 1994, the Company obtained a non-transferable limited exclusive 
license from the Regents of the University of California (Lawrence Livermore 
National Laboratory) to certain "pulse-echo," "ultra-wideband" radar 
technology for use in the following passenger vehicle applications: 
intelligent cruise control, airbag crash systems, and occupant sensors (the 
"LLNL Radar"). This type of radar sends out from one to two million short 
radio impulses every second to a distance of 5 to 10 meters, each lasting a 
billionth of a second. These short impulses enable the radar to operate 
across a wider and lower band of radio frequency, making it less likely to 
suffer from interference from other radar signals, and allowing it to 
penetrate dirt, snow and ice. The Lawrence Livermore National Laboratory 
("LLNL") license required the Company to achieve commercial sales (defined as 
sales of non-prototype products to at least one original equipment 
manufacturer) of products by the end of 1998 or the license would become 
non-exclusive. The Company did not achieve this and the license is now 
non-exclusive and is available to other companies.

Nevertheless, the Company intends to continue to pursue radar products with 
its own radar technology which is different than the LLNL Radar. This system, 
called Swept-range Wideband Radar, provides improved range information and 
noise immunity compared to the LLNL Radar with a slightly higher system cost. 
Swept-range Radar is intended for applications requiring more accurate range 
data such as in Precision Parking, Lane Change, Safety Restraint and Active 
Suspension Systems. See "Proprietary Rights and Patents - Radar for 
Maneuvering and Safety."

The Company has applied its technology to develop demonstration prototypes of 
a parking aid and a lane change aid. The parking aid detects a vehicle or 
other object that reflects radar signals behind the automobile and provides 
an audible or visual signal as the driver approaches it. The lane change aid 
detects vehicles to the side of the automobile when the driver attempts to 
turn or change lanes and emits an audible warning signal. The Company has 
received contracts from a number of automotive manufacturers to design 
evaluation prototypes for both the parking and lane change aids. These 
products are now under evaluation by prospective customers. The Company's 
near-term objective is to obtain further development agreements from some of 
these and other prospective customers to customize the system design during 
1999. No assurance can be given that the Company will obtain any such further 
development agreements. See "Item 1 Risk Factors - Limited Marketing 
Capabilities; Uncertainty of Market Acceptance," "Competition; Possible 
Obsolescence of Technology," "Exclusive License on Heated and Cooled Seats; 
Nonexclusive License on Radar Technology," and "Dependence on Acceptance by 
Automobile Manufacturers and Consumers; Market Competition."

On April 2, 1998 the Company entered into a joint research project with New 
Mexico State Highway and Transportation Department (NMSHTD) Research Bureau 
to test the Company's radar for New Mexico's Highway Maintenance and 
Construction Departments. In the project, the Company's radar was installed 
in heavy construction equipment used by the department and lights and a 
buzzer warn vehicle operators if an object is behind the vehicle when it is 
in reverse. Detected objects include people, posts, vehicles, walls and other 
structures. During a 16 week field testing, four dump trucks and a passenger 
van were equipped with the Company's radar product. Two phases of the three 
phase project were successfully completed in 1998 and the NMSHTD Research 
Bureau approved the final phase of the project in December of 1998. The 
NMSHTD operates a fleet of approximately 5,000 vehicles and successful 
completion of Phase III may entail the installation of the Company's radar 
product in some of those vehicles.

The Company believes it has generated interest in its radar product from 
other State's Departments of Transportation. Management believes there may be 
a market opportunity to equip trucks and heavy construction equipment with 
its radar product as an after-market item. Because of the long design cycles 
required before the Company's radar can become a feature in consumer vehicles 
by sales to automobile and truck OEMs, the Company's probability of sales of 
radar products in the vehicle after-market in the near term are superior than 
its commercial prospects for radar product sales to OEMs.

                                       2



Several automotive OEMs are now offering ultrasonic or infrared laser 
distance sensors for parking aids. The Company believes that the advantage of 
its radar technology is superior performance. Competing products in the 
automotive industry have utilized ultrasonic and infrared sensors which 
require line of sight from the sensor to the target and installation with 
outside lenses. Dirt, ice, rain, fog or snow can obstruct the function of 
such systems. Although they offer reasonable accuracy at short distances, 
they are comparatively range-limited and are subject to false trigger 
problems due to interference with the required line of sight. The Company's 
radar technology, on the other hand, is less susceptible to these 
environmental conditions, and can even penetrate plastic, allowing it to be 
mounted inside plastic bumpers or tail light assemblies. Although there is 
currently considerable interest among automobile manufacturers for various 
radar products, there is substantial competition from large and 
well-established companies for these potential product opportunities, as well 
as for possible industrial applications. Many of these companies have 
substantially greater financial and other resources than those of the 
Company. In addition, considerable research and development will be required 
to develop the Company's radar technology into finished products, including 
design and development of application software and antenna systems and 
production engineering to reduce costs and increase reliability. No assurance 
can be given that the Company will be successful in reducing costs or 
increasing reliability or that the Company will be able to develop its radar 
technology into finished products.

INTERACTIVE VOICE SYSTEMS (IVS-TM-)

On July 24, 1997 the Company entered into a joint venture agreement with 
Yazaki Corporation to develop and market the Company's voice activated 
navigation system. Under the terms of the agreement, IVS, Inc. was created 
and Yazaki Corporation owns a majority interest in IVS-TM- and the Company 
owns a minority interest (16% on a fully diluted basis). The Company received 
$1,800,000 in cash and a note receivable for $1,000,000 in consideration for 
net assets related to Amerigon's voice interactive technology totaling 
approximately $89,000. In addition, the Company incurred costs of $348,000 
associated with the sale. At the end of 1998, due to delays in product 
development, Yazaki Corporation decided to discontinue funding for the joint 
venture. IVS-TM- is exploring other financing alternatives and possible 
bankruptcy proceedings. Amerigon will not provide any funds to continue IVS' 
operation.

PROPOSED DISPOSITION OF ELECTRIC VEHICLE OPERATIONS

The Company was originally founded to focus on advanced automotive 
technologies, including electric vehicles. The Company spent many years 
developing and conducting research on electric vehicles. The Company was the 
recipient of a number of federal and state government grants relating to the 
development of electric vehicles. It also had research and development 
contracts with commercial companies relating to electric vehicles. During 
1995 and 1996, the majority of the Company's revenues were from electric 
vehicle operations. However, the Company incurred substantial losses from 
electric vehicle activities, including significant cost overruns on an 
electric vehicle development contract. By December 31, 1997, substantially 
all work had been completed on the Company's electric vehicle contracts.

By developing its own products and managing programs related to electric 
vehicles (such as the Showcase Electric Vehicle Program and the Running 
Chassis Program), the Company has developed a base of knowledge and expertise 
concerning electric vehicles. The Company's experience has included the 
ground-up design of electric vehicles and testing and integration of state of 
the art components being made available for electric vehicles by other 
companies. In addition, the Company has been developing an "Energy Management 
System" which is a proprietary computer-based system for electric vehicles 
with two functions. The first is to optimize battery charging and use based 
on the age and condition of the battery to maximize vehicle range and extend 
battery life. The second function is to automatically adjust the operation of 
the systems of an electric vehicle to improve performance. These features of 
the Energy Management System are important in electric vehicle applications 
because the range of electric vehicles initially will be limited to 
approximately 60 to 120 miles between charges, and because the frequency of 
battery replacement may be more important in determining the cost of 
operating an electric vehicle than the cost of the electricity necessary to 
recharge the battery. The Company has completed initial research and 
development of prototype Energy Management Systems and has installed them in 
prototype vehicles.

During 1997, the Board of Directors determined to focus the Company's 
activities primarily on the CCS and radar products. The Company began 
actively looking for a strategic partner for the electric vehicle business to 
engage in a joint venture or to provide funding for electric vehicle 
operations. The Company also sought to form a joint venture to manufacture, 
sell and service a small electric car in India (this effort had been ongoing 
since at least 1996). During this time, the Company substantially reduced its 
expenditures for electric vehicle activities but maintained key personnel in 
an attempt to find a joint 

                                       3



venture partner or some other means of deriving value from its electric 
vehicle technologies. The Company attempted to obtain either a strategic 
partner who would, among other things, provide financing for an electric 
vehicle joint venture, or a purchaser for the Company's electric vehicle 
assets, in each case without success. As a result, in 1998 the Board of 
Directors decided to suspend funding the electric vehicle program (effective 
August 1998) because it was generating continuing losses and utilizing 
resources that the Board felt would be better utilized in development of the 
CCS and radar products. Dr. Bell, the Company's founder and Chairman of the 
Board, believed that there were still commercial opportunities worth pursuing 
and agreed to temporarily fund the program personally, in return for a 15% 
interest in the subsidiary in which the electric vehicle assets were to be 
placed (the "EV Sub"). The 15% interest was transferred to Dr. Bell in March 
of 1999. The Board approved this proposal and the Company continued to seek a 
strategic partner.

In December 1998, the Company entered into a letter agreement with a group of 
companies controlled by Sudarshan K. Maini (the "Maini Group") in relation to 
a joint venture to produce electric vehicles in India (the "Indian JV"). 
Under the terms of that letter agreement, the Company will receive (i) a 
minority equity position in a yet to be formed Indian company and (ii) 
royalties on sales of electric vehicles by the Indian JV, both in exchange 
for contribution of certain assets and technology to the Indian JV. However, 
to fully launch the Indian JV, external financing for the Indian JV must be 
obtained as neither the Company nor the Maini Group has committed the 
necessary funding for the Indian JV.

In connection with a proposed financing for the Company which is described 
more fully in "Item 7 Management's Discussion and Analysis -- Liquidity and 
Capital Resources" (the "Proposed Financing"), the investors require that the 
Company redeem from Dr. Bell the Class B Shares of the Company that he and/or 
his affiliates will hold upon the termination of the escrow that was created 
in connection with the Company's initial public offering of securities in 
1993. Dr. Bell has entered into an agreement to sell to the Company those 
Class B Shares in exchange for the remaining 85% equity interest in the EV 
Sub, subject to the closing of the Proposed Financing and shareholder 
approval of the exchange transaction (the "Exchange"). If the Exchange is 
effected, the Company will have no further ownership interest in the EV Sub 
but will retain the right to receive from the EV Sub payment of 85% of the 
royalties which the EV Sub receives from the Indian JV, if any. The EV Sub 
will have all other rights to the Company's electric vehicle technology. If 
the proposed financing is completed but the shareholders do not approve of 
the Exchange of the EV Sub to Dr. Bell for the Class B Shares, then the Class 
B Shares will be redeemed for cash and Dr. Bell will be granted rights to 
control the board of directors of the EV Sub and co-sale rights and rights of 
first refusal with respect to any disposition by the Company of its interests 
in the EV Sub. The investors have indicated that they do not intend to 
continue funding electric vehicle operations whether or not the Company 
maintains any ownership interest in the EV Sub.

GRANT FUNDED PROGRAMS

The Company has historically received grants from various sources to provide 
partial support for its product development efforts. Most grants received by 
the Company related to electric vehicle operations. A grant is essentially a 
cost-sharing arrangement whereby the Company obtains reimbursement from the 
grant agency for a portion of direct costs and reimbursable administrative 
costs incurred in managing specific development programs. The Company's 
grants have historically been subject to periodic audit by the granting 
government authorities for the purpose of confirming, among other things, 
progress in development and that grant moneys were being used and accounted 
for as required by the granting authority. If, as a result of any such audit, 
a granting authority were to disallow expenses submitted for reimbursement, 
such authority could seek recovery of such funds from the Company. The 
Company is not aware of any pending or threatened audits with respect to the 
Company's grants and does not have any reason to believe that any grant 
moneys have been applied in a manner inconsistent with grant requirements or 
that any grant audits are otherwise warranted or likely. However, no 
assurance can be given that any such audits will not be commenced in the 
future or that, if commenced, any such audits would not result in an 
obligation of the Company to reimburse funds to the granting authority.

Since 1992, the Company has received grants from the Advanced Research 
Projects Agency of the Department of Defense, the California Energy 
Commission, the Federal Transit Administration, and the Southern California 
Air Quality Management District and USAID. Several of the Company's 
grant-funded programs have been obtained through CALSTART, a non-profit 
consortium of primarily California companies engaged in the development and 
manufacture of products that benefit the environment. The Company managed the 
Showcase Program, co-managed the Neighborhood Electric Vehicle Program, and 
two other electric vehicle programs for CALSTART, for which the Company 
recognized revenues from CALSTART of approximately $0, $389,000 and $840,000 
in 1998, 1997 and 1996, respectively.

For the years ended December 31, 1998, 1997 and 1996, the Company recorded a 
total of $0, $504,000 and $1,172,000, respectively, in federal and state 
government grants to fund the Company's development of various of its 
products, including electric vehicles. The Company has significantly reduced 
its efforts to obtain any additional grants and intends to focus its efforts 
on working toward production contracts for CCS and radar sensor systems.

                                       4



RESEARCH AND DEVELOPMENT

The Company's research and development activities are an essential component 
of the Company's efforts to develop products for introduction in the 
marketplace. The Company's research and development activities are expensed 
as incurred. These expenses include direct expenses for wages, materials and 
services associated with development contracts, grant program activities, and 
the development of the Company's products, excluding expenses associated with 
projects that are specifically funded by development contracts or grant 
agreements from customers (which are classified under Direct Development 
Contract and Related Grant Costs or Direct Grant Costs in the Company's 
Statement of Operations). Research and development expenses do not include 
any portion of general and administrative expenses.

The total amounts spent by the Company for research and development 
activities in 1998, 1997 and 1996 were $3,202,000, $2,072,000 and $2,128,000, 
respectively. Included in these amounts for each of such years were $43,000, 
$260,000 and $298,000, respectively, in payments for license rights to 
technology and minimum royalties. The Company's research and development 
expenses fluctuate significantly from period to period, due both to changing 
levels of research and development activity and changes in the amount of such 
activities that are covered by customer contracts or grants. Where possible, 
the Company would seek funding from third parties for its research and 
development activities. Customer-sponsored research and development expenses 
(i.e., expenses classified as Direct Development Contract and Related Grant 
Costs or Direct Grant Costs on the Company's Statement of Operations) for 
each of 1998, 1997 and 1996 were $1,364,000, $2,611,000 and $11,743,000, 
respectively.

MARKETING AND SALES

In the automotive components industry, products typically proceed through 
five stages of research and development and commercialization. Initial 
research on the product concept comes first, in order to assess its technical 
feasibility and economic costs and benefits, and often includes the 
development of an internal prototype for the supplier's own evaluation of the 
product. If the product appears feasible, a functioning prototype or 
demonstration prototype is manufactured by the component supplier to 
demonstrate and test the features of the product. This prototype is then 
marketed to automotive companies to generate sales of evaluation prototypes 
for internal evaluation by the automobile manufacturer. If the automobile 
manufacturer remains interested in the product after testing initial 
evaluation prototypes, it typically works with the component supplier to 
refine the product and then purchase second and subsequent generation 
engineering prototypes for further evaluation. Finally, the automobile 
manufacturer determines to either purchase the component for a production 
vehicle or terminate interest in the component.

The time required to progress through these five stages of commercialization 
varies widely. Automotive companies will take longer to evaluate components 
that are critical to the safe operation of a vehicle where a product failure 
can result in a passenger death. Conversely, if the product is not safety 
critical, the evaluation can proceed more quickly since the risk of product 
liability is smaller. Another factor influencing the time required to 
complete the product sales cycle relates to the required level of integration 
of the component into other vehicle systems. Products that are installed by 
the factory generally require a medium amount of time to evaluate since other 
vehicle systems are affected and because a decision to introduce the product 
into the vehicle is not easily reversed, as it is with dealer-installed 
options. Products that are installed by an auto dealer take the least amount 
of time to evaluate since they have little impact on other vehicle systems. 
The Company's products vary in how they fit within these two factors 
affecting the time required for completing the sales cycle. The CCS has a 
moderate effect on other vehicle systems and would be a factory installed 
item. The Company's radar system could also be factory installed and would 
have a greater impact on other vehicle systems. The radar system could also 
be sold as an after-market item for trucks.

The Company's ability to successfully market its CCS and radar products will 
in large part be dependent upon, among other things, the willingness of 
automobile manufacturers to incur the substantial expense involved in the 
purchase and installation of the Company s products and systems, and, 
ultimately, upon the acceptance of the Company's products by consumers. In 
addition, automobile manufacturers may be reluctant to purchase key 
components from a small, development-stage company with limited financial and 
other resources. Even if the Company is successful in obtaining favorable 
responses from automobile manufacturers, the Company may need to license its 
technology to potential competitors to ensure adequate additional sources of 
supply in light of automobile manufacturers' reluctance to purchase products 
from a sole source supplier (particularly where the continued viability of 
such supplier is in doubt, as may be the case with the Company). See "Item 1 
Risk Factors Dependence on Acceptance by Automobile Manufacturers and 
Consumers; Market Competition," "Competition; Possible Obsolescence of 
Technology"; "Nonexclusive License on Radar Technology" and "Limited 
Marketing Capabilities; Uncertainty of Market Acceptance"

                                       5



MANUFACTURING, CONTRACTORS AND SUPPLIERS

The Company currently has limited manufacturing capacity for CCS systems. The 
Company intends to develop further its manufacturing capability in order to 
implement its business plan, control product quality and delivery, to shorten 
product development cycle times, and protect and further develop proprietary 
technologies and processes. This capability could be developed internally 
through the purchase or development of new equipment and the hiring of 
additional personnel, or through the acquisition of companies with 
established manufacturing capability. Certain members of management of the 
Company have experience in establishing and managing volume production of 
automobile components. There can be no assurance that the Company's efforts 
to establish its manufacturing operations for any of its products will not 
exceed estimated costs or take longer than expected or that other anticipated 
problems will not arise that will materially adversely affect the Company's 
operations, financial condition and/or business prospects. See "Item 7 
Management's Discussion and Analysis of Financial Condition and Results of 
Operations Year Ended December 31, 1998 Compared to Year Ended December 31, 
1997."

The Company has in the past engaged certain outside contractors to perform 
product assembly and other production functions for the Company, and the 
Company anticipates that it may desire to engage contractors for such 
purposes in the future. These outside contractors include suppliers of raw 
materials and components and may include sublicensees that have rights to 
manufacture components for the Company's products. The Company believes that 
there are a number of outside contractors that provide services of the kind 
that have been used by the Company in the past and that the Company may 
desire to use in the future. However, no assurance can be given that any such 
contractors would agree to work for the Company on terms acceptable to the 
Company or at all. The Company's inability to engage outside contractors on 
acceptable terms or at all would impair the Company's ability to complete any 
development and/or manufacturing contracts for which outside contractors' 
services may be needed. Moreover, the Company's reliance upon third party 
contractors for certain production functions will reduce the Company's 
control over the manufacture of its products and will make the Company 
dependent in part upon such third parties to deliver its products in a timely 
manner, with satisfactory quality controls and on a competitive basis.

The Company relies on various vendors and suppliers for the components of its 
products. The Company expects that it will procure these components through 
purchase orders, with no guaranteed supply arrangements. While the Company 
believes that there are a number of alternative sources for most of these 
components, certain components, including thermoelectric devices, are only 
available from a limited number of suppliers. The loss of any significant 
supplier, in the absence of a timely and satisfactory alternative 
arrangement, or an inability to obtain essential components on reasonable 
terms or at all, could materially adversely affect the Company's business and 
operations. The Company's business and operations could also be materially 
adversely affected by delays in deliveries from suppliers.

PROPRIETARY RIGHTS AND PATENTS

The Company acquires developed technologies through licenses and joint 
development contracts in order to optimize the Company's expenditure of 
capital and time, and to adapt and commercialize such technologies in 
automotive products which are suitable for mass production. The Company also 
develops technologies or furthers the development of acquired technologies 
through internal research and development efforts by Company engineers.

The Company has adopted a policy of seeking to obtain, where practical, the 
exclusive rights to use technology related to its products through patents or 
licenses for proprietary technologies or processes. The Company currently has 
several license arrangements.

CCS

Pursuant to an Option and License Agreement between the Company and Feher 
Design, Inc. ("Feher"), Feher has granted to the Company an exclusive 
worldwide license to use three specific CCS technologies covered by patents 
held by Feher. The license with respect to technology subject to a Feher 
patent expires upon the expiration of the Feher patent covering the relevant 
technology. The first of these three patents expires on November 17, 2008.

In addition to the aforementioned license rights to the CCS technology, the 
Company holds three patents on a variable temperature seat climate control 
system. The Company also has pending two additional patent applications with 
respect to certain improvements to the CCS technology developed by the 
Company. The Company is aware that an unrelated party filed a patent 
application in Japan on March 30, 1992 with respect to technology similar to 
the CCS technology. However, to 

                                       6



date, this application remains subject to examination and therefore no patent 
has been issued to the party filing such application. If such patent were to 
issue and be upheld, it could have a material adverse effect upon the 
Company's ability to sell CCS products in Japan.

RADAR FOR MANEUVERING AND SAFETY

Pursuant to a License Agreement between the Company and the Regents (the 
"Regents") of the University of California (Lawrence Livermore National 
Laboratory), the Regents granted to the Company a limited, exclusive license 
to use certain technology covered by patents held by the Regents in the 
following three passenger vehicle applications: intelligent cruise control, 
air bag crash systems, and position sensors. This license required the 
Company to achieve commercial sales of products by the end of 1998. 
Commercial sales were defined as sales of non-prototype products to at least 
one original equipment manufacturer. Since commercial sales volumes were not 
achieved, the exclusivity on the license has lapsed. Although the Company 
retains its license, other companies may also acquire the license and develop 
products based on the technology.

The Company holds one patent on radar technology. See "Item 1 Risk Factors 
Dependence on Acceptance by Automobile Manufacturers and Consumers; Market 
Competition," "Time Lag From Prototype to Commercial Sales," "Special Factors 
Applicable to the Automotive Industry In General," and "Competition; Possible 
Obsolescence of Technology." At December 31, 1998, the Company also had 
pending one additional patent application on its radar technology.

ELECTRIC VEHICLE SYSTEMS

The Company was issued a patent on a key function of the Energy Management 
System and has applied for additional patents relating to such system. The 
Company believes that those elements of the Energy Management System not 
covered by the patent are protected as trade secrets. The Company's Energy 
Management System technology is now part of the EV Sub, a subsidiary created 
as a result of the Board of Director's decision in August of 1998 to suspend 
funding of the electric vehicle program and Dr. Bell's resulting offer to 
continue funding the electric vehicle program in return for a 15% stake in a 
subsidiary to be formed which contains the electric vehicle assets. Pursuant 
to the Proposed Financing, the EV Sub may be sold to Dr. Bell in exchange for 
the redemption of his Class B Shares held by him or his affiliates. See 
"Proposed Disposition of Electric Vehicle Operations."

GENERAL

Because of rapid technological developments in the automotive industry and 
the competitive nature of the market, the patent position of any component 
manufacturer is subject to uncertainties and may involve complex legal and 
factual issues. Consequently, although the Company either owns or has 
licenses to certain patents, and is currently processing several additional 
patent applications, it is possible that no patents will issue from any 
pending applications or that claims allowed in any existing or future patents 
issued or licensed to the Company will be challenged, invalidated, or 
circumvented, or that any rights granted thereunder will not provide adequate 
protection to the Company. There is an additional risk that the Company may 
be required to participate in interference proceedings to determine the 
priority of inventions or may be required to commence litigation to protect 
its rights, which could result in substantial costs to the Company.

The Company's potential products may conflict with patents that have been or 
may be granted to competitors or others. Such other persons could bring legal 
actions against the Company claiming damages and seeking to enjoin 
manufacturing and marketing of the affected products. Any such litigation 
could result in substantial cost to the Company and diversion of effort by 
the Company's management and technical personnel. If any such actions are 
successful, in addition to any potential liability for damages, the Company 
could be required to obtain a license in order to continue to manufacture or 
market the affected products. There can be no assurance that the Company 
would prevail in any such action or that any license required under any such 
patent would be made available on acceptable terms, if at all. Failure to 
obtain needed patents, licenses or proprietary information held by others may 
have a material adverse effect on the Company's business. In addition, if the 
Company becomes involved in litigation, it could consume a substantial 
portion of the Company's time and resources. However, the Company has not 
received any notice that its products infringe on the proprietary rights of 
third parties.

The Company also relies on trade secrets that it seeks to protect, in part, 
through confidentiality and non-disclosure agreements with employees, 
customers and other parties. There can be no assurance that these agreements 
will not be breached, that the Company would have adequate remedies for any 
such breach or that the Company's trade secrets will not otherwise become 
known to or independently developed by competitors. To the extent that 
consultants, key employees or other third parties apply technological 
information independently developed by them or by others to the Company's 

                                       7



proposed projects, disputes may arise as to the proprietary rights to such 
information that may not be resolved in favor of the Company. The Company may 
be involved from time to time in litigation to determine the enforceability, 
scope and validity of proprietary rights. Any such litigation could result in 
substantial cost to the Company and diversion of effort by the Company's 
management and technical personnel. Additionally, with respect to licensed 
technology, there can be no assurance that the licensor of the technology 
will have the resources, financial or otherwise, or desire to defend against 
any challenges to the rights of such licensor to its patents.

The enactment of the legislation implementing the General Agreement on Trade 
and Tariffs has resulted in certain changes to United States patent laws that 
became effective on June 8, 1995. Most notably, the term of patent protection 
for patent applications filed on or after June 8, 1995 is no longer a period 
of 17 years from the date of grant. The new term of a United States patent 
will commence on the date of issuance and terminate 20 years from the 
earliest effective filing date of the application. Because the time from 
filing to issuance of an automotive technology patent application is often 
more than three years, a 20-year term from the effective date of filing may 
result in a substantially shortened term of patent protection, which may 
adversely impact the Company's patent position. If this change results in a 
shorter period of patent coverage, the Company's business could be adversely 
affected to the extent that the duration and/or level of the royalties it may 
be entitled to receive from a collaborative partner, if any, is based on the 
existence of a valid patent.

COMPETITION

The automotive components and systems business is highly competitive. The 
Company may experience competition directly from automobile manufacturers, 
most of which have the capability to manufacture competing products. Many of 
the existing and potential competitors of the Company have considerably 
greater financial and other resources than the Company, including, but not 
limited to, an established customer base, greater research and development 
capability, established manufacturing capability and greater marketing and 
sales resources. The Company also competes indirectly with related products 
that do not offer equivalent features to the Company's products, but can 
substitute for the Company's products, such as heated seats, ventilated seats 
and ultrasonic radar products. The Company believes that its products will 
compete on the basis of price, performance and quality.

CCS

The Company is not aware of any competitors that are offering systems for 
both heating and active cooling of automotive car seats, although substantial 
competition exists for the supply of heated-only seats and several companies 
are offering a product which circulates ambient air through a seat without 
active cooling. In addition Mercedes Benz has announced an option on certain 
new models which combines heated seats with circulation of ambient air. It is 
possible that competitors will be able to expand or modify their current 
products by adding a cooling function to their seats based upon a technology 
not covered by patented technology licensed to the Company. The CCS competes 
indirectly with alternative methods of providing passenger climate control in 
a vehicle such as heating and air conditioning systems, which are currently 
available for almost all vehicles. The Company hopes to develop a market 
niche for this product initially as a luxury in conventional gasoline-powered 
cars and sport utility vehicles. The Company is aware that a Japanese patent 
has been applied for by another entity on technology similar to the CCS 
technology.

RADAR FOR MANEUVERING AND SAFETY

The potential market for automotive radar has attracted many aerospace 
companies who have developed a variety of radar technologies. A few 
automotive OEMs are now offering ultrasonic or infrared laser distance 
sensors for parking aids. These companies have far greater technical, 
financial and other resources than the Company does. While the Company 
believes that its licensed radar technology has competitive advantages which 
are protected by intellectual property rights in the applications the Company 
is developing, it is possible that the market will not accept the Company's 
radar products or that competitors will find ways to offer similar products 
without infringing on the Company's intellectual property rights.

EMPLOYEES

As of December 31, 1998, the Company had 44 employees and 5 outside 
contractors. None of the Company's employees are subject to collective 
bargaining agreements. The Company considers its employee relations to be 
satisfactory.

RISK FACTORS

                                       8



THE COMPANY'S SECURITIES ARE HIGHLY SPECULATIVE IN NATURE AND INVOLVE A HIGH 
DEGREE OF RISK. PRIOR TO MAKING AN INVESTMENT DECISION, CURRENT AND 
PROSPECTIVE INVESTORS IN THE COMPANY'S SECURITIES SHOULD GIVE CAREFUL 
CONSIDERATION TO, AMONG OTHER THINGS, THE RISK FACTORS SET FORTH BELOW. THIS 
REPORT CONTAINS FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF THE "SAFE 
HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. 
REFERENCE IS MADE IN PARTICULAR TO THE DESCRIPTION OF THE COMPANY'S PLANS AND 
OBJECTIVES FOR FUTURE OPERATIONS, ASSUMPTIONS UNDERLYING SUCH PLANS AND 
OBJECTIVES AND OTHER FORWARD-LOOKING STATEMENTS INCLUDED IN THIS SECTION, 
"ITEM 1 BUSINESS," "ITEM 7 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL 
CONDITION AND RESULTS OF OPERATIONS," AND IN OTHER PLACES IN THIS REPORT. 
SUCH STATEMENTS MAY BE IDENTIFIED BY THE USE OF FORWARD-LOOKING TERMINOLOGY 
SUCH AS "MAY," "WILL" "EXPECT" "BELIEVE," "ESTIMATE," "ANTICIPATE" "INTEND," 
"CONTINUE," OR SIMILAR TERMS, VARIATIONS OF SUCH TERMS OR THE NEGATIVE OF 
SUCH TERMS. SUCH STATEMENTS ARE BASED ON MANAGEMENT'S CURRENT EXPECTATIONS 
AND ARE SUBJECT TO A NUMBER OF FACTORS AND UNCERTAINTIES WHICH COULD CAUSE 
ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE DESCRIBED IN THE 
FORWARD-LOOKING STATEMENTS. THE COMPANY EXPRESSLY DISCLAIMS ANY OBLIGATION OR 
UNDERTAKING TO RELEASE PUBLICLY ANY UPDATES OR REVISIONS TO ANY 
FORWARD-LOOKING STATEMENTS CONTAINED HEREIN TO REFLECT ANY CHANGE IN THE 
COMPANY'S EXPECTATIONS WITH REGARD THERETO OR ANY CHANGE IN EVENTS, 
CONDITIONS OR CIRCUMSTANCES ON WHICH ANY SUCH STATEMENT IS BASED. FACTORS 
WHICH COULD CAUSE SUCH RESULTS TO DIFFER MATERIALLY FROM THOSE DESCRIBED IN 
THE FORWARD-LOOKING STATEMENTS INCLUDE THOSE SET FORTH BELOW.

DEVELOPMENT STAGE COMPANY

The Company's proposed future operations are subject to numerous risks 
associated with establishing new businesses, including, but not limited to, 
availability of capital, unforeseeable expenses, delays and complications, as 
well as specific risks of the industry in which the Company competes. There 
can be no assurance that the Company will be able to market any product on a 
commercial scale, achieve profitable operations or remain in business. To 
date, the Company's first developed product, the interactive voice navigation 
system was not commercially successful. See "Item 1 Business" herein. The 
Company was formed in April 1991 and its principal products are still in the 
development or pre-production stage. The likelihood of the success of the 
Company must be considered in light of the problems, expenses, difficulties, 
complications and delays frequently encountered in connection with 
establishing a new business, including, without limitation, uncertainty as to 
market acceptance of the Company's products, marketing problems and expenses, 
competition and changes in business strategy. There can be no assurance that 
the Company will be successful in its proposed business activities.

Moreover, the Company's radar systems are in various stages of 
prototype/pre-production development and will require the expenditure of 
significant funds for further development and testing in order to commence 
commercial sales. No assurance can be given that the Company will obtain the 
funds necessary to pay for such further development of its products or that, 
if such funds are obtained, the Company will be successful in resolving all 
technical problems relating to its products or in developing the technology 
used in its prototypes into commercially viable products. The Company does 
not expect to generate significant revenues from the sale of seat or radar 
products for at least 12 months, and no assurance can be given that such 
sales will ever materialize. Further, there can be no assurance that any of 
the Company's products, if successfully developed, will be capable of being 
produced in commercial quantities at reasonable costs or will be successfully 
marketed and distributed. See "Limited Marketing Capabilities; Uncertainty of 
Market Acceptance."

SUBSTANTIAL OPERATING LOSSES SINCE INCEPTION

The Company has incurred substantial operating losses since its inception. At 
December 31, 1998 and 1997, the Company had accumulated deficits since 
inception of $36,305,000 and $28,601,000, respectively. See "Item 7 
Management's Discussion and Analysis of Financial Condition and Results of 
Operations." The Company's accumulated deficits are attributable to the costs 
of developmental and other start-up activities, including the industrial 
design, development and marketing of the Company's products and a significant 
loss incurred on a major electric vehicle development contract. The Company 
has continued to incur losses due to continuing expenses without significant 
revenues or profit margins on the sale of products, and expects to incur 
significant losses for the foreseeable future

PROPOSED FINANCING; CHANGE OF CONTROL

On March 29, 1999, the Company entered into a Securities Purchase Agreement 
with Westar Capital II LLC and Big Beaver Investments LLC (the "Investors") 
pursuant to which the Investors will invest $9 million in the Company in 
return for 9,000 shares of a Series A Preferred Stock (which are convertible 
into Class A Common Stock at an initial conversion price of $1.675 per common 
share) and Contingent Warrants. The Contingent Warrants are exercisable only 
to the extent certain other warrants to purchase Class A Common Stock are 
exercised, and then only in an amount that will enable the Investors to 
maintain the same percentage interest in the Company that they have in the 
Company after the initial investment (on an as converted basis). In 
connection with this transaction, the Investors would obtain the right to 
elect a majority of the 

                                       9



Company's directors as well as rights of first refusal to provide additional 
financing for the Company and registration rights. In addition, based upon 
the Company's existing capitalization and the proposed terms of the Series A 
Preferred Stock, immediately following the proposed investment, the Investors 
would have approximately 74% of the Company's common equity (on an as 
converted basis, excluding options and warrants). Completion of the proposed 
financing is subject to a number of conditions, including shareholder 
approval, which the Company intends to seek at the 1999 Annual Shareholders 
Meeting. There can be no assurance that the proposed equity financing will be 
completed.

Concurrent with the execution of the Securities Purchase Agreement, an 
affiliate of the Investors provided a secured credit facility (the "Bridge 
Loan") to the Company for up to $1.2 million which bears interest at 10% per 
annum and matures on the earlier of September 30, 1999 or the completion of 
the equity financing. As additional consideration for the Bridge Loan, the 
Company issued detachable five year warrants to purchase 300,000 shares of 
Class A Common Stock at $1.03 per share, subject to adjustment. The bridge 
warrants will be cancelled upon the completion of the equity investment with 
the Investors. The Bridge Loan is secured by a lien on virtually all of the 
Company's assets. The Bridge Loan is necessary to allow the Company to 
continue operations pending the closing of the equity financing, although the 
amount of the Bridge Loan may not be adequate even if fully drawn. Further, 
there are numerous conditions to making each borrowing under the Bridge Loan.

NEED FOR ADDITIONAL FINANCING

The Company has experienced negative cash flow from operations since its 
inception and has expended, and expects to continue to expend, substantial 
funds to continue its development efforts. The Company has not generated and 
does not expect to generate in the near future sufficient revenues from the 
sales of its principal products to cover its operating expenses. 
Notwithstanding the proposed financing described above, the Company will 
require additional financing through bank borrowings, debt or equity 
financing or otherwise to finance its planned operations. If additional funds 
are not obtained when needed, the Company will be required to significantly 
curtail its activities, dispose of one or more of its technologies and/or 
cease operations and liquidate. If and when the Company is able to commence 
commercial volume production of its heated and cooled seat or radar products, 
the Company will incur significant expenses for tooling product parts and to 
set up manufacturing and/or assembly processes. No assurance can be given 
that such alternate funding sources can be obtained or will provide 
sufficient, or any, financing for the Company.

PROPOSED DISPOSITION OF ELECTRIC VEHICLE OPERATIONS

In 1998, the Board of Directors decided to suspend funding the electric 
vehicle program (effective August 1998) because it was generating continuing 
losses and utilizing resources that the Board felt would be better utilized 
in development of the CCS and radar products. Dr. Bell, the Company's founder 
and Chairman of the Board, believed that there were still commercial 
opportunities worth pursuing and agreed to fund the program personally, in 
return for a 15% interest in the EV Sub. The Board approved this proposal and 
the Company continued to seek a strategic partner.

In December 1998, the Company entered into a letter agreement with the Maini 
Group in relation to the Indian JV. Under the terms of that letter agreement, 
the Company will receive (i) a minority equity position in a yet to be formed 
Indian company and (ii) royalties on sales of electric vehicles by the Indian 
JV, both in exchange for contribution of certain assets and technology to the 
Indian JV. However, to fully launch the Indian JV, external financing for the 
Indian JV must be obtained as neither the Company nor the Maini Group has 
committed the necessary funding for the Indian JV.

In connection with the proposed financing for the Company which is described 
above and in "Item 7 Management's Discussion and Analysis -- Liquidity and 
Capital Resources", the Investors require that the Company redeem from Dr. 
Bell the Class B Shares of the Company that he and/or his affiliates will 
hold upon the termination of the escrow that was created in connection with 
the Company's initial public offering of securities in 1993. Dr. Bell has 
entered into a Share Exchange Agreement to sell to the Company those Class B 
Shares in exchange for the remaining 85% equity interest in the EV Sub, 
subject to the closing of the proposed financing and shareholder approval of 
the exchange transaction. If the exchange is effected, the Company will have 
no further ownership interest in the EV Sub but will retain the right to 
receive from the EV Sub payment of 85% of the royalties which the EV Sub 
receives from the Indian JV, if any. The EV Sub will have all other rights to 
the Company's electric vehicle technology. If the proposed financing is 
completed but the shareholders do not approve of the sale of the EV Sub to 
Dr. Bell for the Class B Shares, then the Class B Shares will be redeemed for 
cash and Dr. Bell will be granted rights to control the board of directors of 
the EV Sub and co-sale rights and rights of first refusal with respect to any 
disposition by the Company of its interests in the EV Sub. The investors have 
indicated that they do no intend to continue funding electric vehicle 
operations whether or not the Company maintains any ownership interest in the 
EV Sub. See "Business--Proposed Disposition of Electric Vehicle Operations."

                                       10



DEPENDENCE ON ACCEPTANCE BY AUTOMOBILE MANUFACTURERS AND CONSUMERS; MARKET 
COMPETITION

The Company's ability to successfully market its CCS and radar products will 
in large part be dependent upon the willingness of automobile manufacturers 
to incur the substantial expense involved in the purchase and installation of 
the Company's products and systems, and, ultimately, upon the acceptance of 
the Company's products by consumers. The Company's potential customers may be 
reluctant to modify their existing automobile models, where necessary, to 
incorporate the Company's products. In addition, automobile manufacturers may 
be reluctant to purchase key components from a small, development-stage 
company with limited financial and other resources. The Company's ability to 
successfully market its seats and radar products will also be dependent in 
part upon its ability to persuade automobile manufacturers that the Company's 
products are sufficiently unique that they cannot be obtained elsewhere. See 
"Competition; Possible Obsolescence of Technology" and "Exclusive Licenses on 
Heated and Cooled Seats;" "Potential Loss of Exclusivity of License on Radar 
for Maneuvering and Safety." There can be no assurance that the Company will 
be successful in this effort. Furthermore, in the event the Company is 
successful in obtaining favorable responses from automobile manufacturers, 
the Company may need to license its technology to potential competitors to 
ensure adequate additional sources of supply in light of automobile 
manufacturers' reluctance to purchase products from a sole source supplier 
(particularly where the continued viability of such supplier is in doubt, as 
may be the case with the Company).

EXCLUSIVE LICENSE ON HEATED AND COOLED SEATS; NON-EXCLUSIVE LICENSE ON RADAR 
TECHNOLOGY

In 1997, the Company negotiated with the licensor of the CCS technology an 
exclusive license for the manufacture and sale of licensed products for 
installation or use in automobiles, trucks, buses, vans and recreational 
vehicles. As part of the agreement, all intellectual property developed by 
Amerigon related to variable temperature seats is owned by Amerigon but such 
licensor will have the right to license Amerigon's technology on a 
non-exclusive basis for use other than in automobiles, trucks, buses, vans 
and recreational vehicles.

The Company's license from LLNL for one type of the Company's radar 
technology became non-exclusive as of December 31, 1998. The lack of 
exclusivity means that the Company has reduced intellectual property 
protection for technology developed from this license and faces possible 
competition from other companies which can acquire this license from LLNL. 
See "Item 1 Business Proprietary Rights and Patents."

LIMITED PROTECTION OF PATENTS AND PROPRIETARY RIGHTS

The Company believes that patents and proprietary rights have been and will 
continue to be important in enabling the Company to compete. There can be no 
assurance that any patents will be granted or that the Company's or its 
licensors' patents and proprietary rights will not be challenged or 
circumvented or will provide the Company with any meaningful competitive 
advantages or that any pending patent applications will issue. Furthermore, 
there can be no assurance that others will not independently develop similar 
products or will not design around any patents that have been or may be 
issued to the Company or its licensors. Failure to obtain patents in certain 
foreign countries may materially adversely affect the Company's ability to 
compete effectively in certain international markets. The Company is aware 
that an unrelated party filed a patent application in Japan on March 30, 1992 
with respect to certain improvements to the CCS technology developed by the 
Company.

The Company holds current and future rights to licensed technology through 
licensing agreements requiring the payment of minimum royalties. The Company 
has prepaid all royalties for the fiscal year ending December 31, 1999, but 
if the Company were unable to pay such royalties or otherwise breached these 
license agreements, the Company would lose its rights to the licensed 
technology. This would materially and adversely affect the Company's business.

The Company also relies on trade secrets that it seeks to protect, in part, 
through confidentiality and non-disclosure agreements with employees, 
customers and other parties. There can be no assurance that these agreements 
will not be breached, that the Company would have adequate remedies for any 
such breach or that the Company's trade secrets will not otherwise become 
known to or independently developed by competitors. To the extent that 
consultants, key employees or other third parties apply technological 
information independently developed by them or by others to the Company's 
proposed projects, disputes may arise as to the proprietary rights to such 
information which may not be resolved in favor of the Company. The Company 
may be involved from time to time in litigation to determine the 
enforceability, scope and validity of proprietary rights. Any such litigation 
could result in substantial cost to the Company and diversion of effort by 
the Company's management and technical personnel. Additionally, with respect 
to licensed technology, there can be no assurance that the licensor of the 
technology will have the resources, financial or otherwise, or desire to 
defend against any 

                                       11



challenges to the rights of such licensor to its patents.

LIMITED MANUFACTURING EXPERIENCE

To date, the Company has been engaged in only limited manufacturing in small 
quantities, and there can be no assurance that the Company's efforts to 
establish its manufacturing operations for any of its products will not 
exceed estimated costs or take longer than expected or that other 
unanticipated problems will not arise which will materially adversely affect 
the Company's operations, financial condition and/or business prospects. The 
Company has already experienced significant delays and cost overruns in 
connection with its electric vehicle contracts. Automobile manufacturers 
demand on-time delivery of quality products, and some have required the 
payment of substantial financial penalties for failure to deliver components 
to their plants on a timely basis. Such penalties, as well as costs to avoid 
them, such as working overtime and overnight air freighting parts that 
normally are shipped by other less expensive means of transportation, could 
have a material adverse effect on the Company's business and financial 
condition. Moreover, the inability to meet demand for the Company's products 
on a timely basis would materially adversely affect the Company's reputation 
and prospects.

LIMITED MARKETING CAPABILITIES; UNCERTAINTY OF MARKET ACCEPTANCE

Because of the sophisticated nature and early stage of development of its 
products, the Company will be required to educate potential customers and 
successfully demonstrate that the merits of the Company's products justify 
the costs associated with such products. In certain cases, however, the 
Company will likely encounter resistance from customers reluctant to make the 
modifications necessary to incorporate the Company's products into their 
products or production processes. In some instances, the Company may be 
required to rely on its distributors or other strategic partners to market 
its products. The success of any such relationship will depend in part on the 
other party's own competitive, marketing and strategic considerations, 
including the relative advantages of alternative products being developed 
and/or marketed by any such party. There can be no assurance that the Company 
will be able to market its products properly so as to generate meaningful 
product sales.

TIME LAG FROM PROTOTYPE TO COMMERCIAL SALES

The sales cycle in the automotive components industry is lengthy and can be 
as long as six years or more for products that must be designed into a 
vehicle, since some companies take that long to design and develop a car. 
Even when selling parts that are neither safety-critical nor highly 
integrated into the vehicle, there are still many stages that an automotive 
supply company must go through before achieving commercial sales. The sales 
cycle is lengthy because an automobile manufacturer must develop a high 
degree of assurance that the products it buys will meet customer needs, 
interface as easily as possible with the other parts of a vehicle and with 
the automobile manufacturer's production and assembly process, and have 
minimal warranty, safety and service problems. The Company has delivered 
prototype units of CCS systems to most of the major automotive and seat 
companies and been selected by a major seat supplier to automotive OEMs to 
supply CCS to be installed on one platform for a major North American auto 
manufacturer. However, no assurance can be given that the achievement of any 
of these milestones will result in production orders or that such orders, if 
obtained, will be received in the near future.

SPECIAL FACTORS APPLICABLE TO THE AUTOMOTIVE INDUSTRY IN GENERAL

The automobile industry is cyclical and dependent on consumer spending. The 
Company's future sales may be subject to the same cyclical variations as the 
automotive industry in general. There have been recent reports of declines in 
sales of automobiles on a worldwide basis, and there can be no assurance that 
continued or increased declines in automobile production would not have a 
material adverse effect on the Company's business or prospects. Additionally, 
automotive customers typically reserve the right to unilaterally cancel 
contracts completely or to require unilateral price reductions. Although they 
generally reimburse companies for actual out-of-pocket costs incurred with 
respect to the particular contract up to the point of cancellation, these 
reimbursements typically do not cover costs associated with acquiring general 
purpose assets such as facilities and capital equipment, and may be subject 
to negotiation and substantial delays in receipts by the Company. Any 
unilateral cancellation of, or price reduction with respect to, any contract 
that the Company may obtain could reduce or eliminate any financial benefits 
anticipated from such contract and could have a material adverse effect on 
the Company's financial condition and results of operations.

COMPETITION; POSSIBLE OBSOLESCENCE OF TECHNOLOGY

The automotive component industry is subject to intense competition. 
Virtually all of the Company's competitors are substantially larger in size, 
have substantially greater financial, marketing and other resources than the 
Company, and have more extensive experience and records of successful 
operations than the Company. Competition extends to attracting and 

                                       12



retaining qualified technical and marketing personnel. There can be no 
assurance that the Company will successfully differentiate its products from 
those of its competitors, that the marketplace will consider the Company's 
current or proposed products to be superior or even comparable to those of 
its competitors, or that the Company can succeed in establishing 
relationships with automobile manufacturers. Furthermore, no assurance can be 
given that competitive pressures faced by the Company will not adversely 
affect its financial performance. Due to the rapid pace of technological 
change, the Company's products may even be rendered obsolete by future 
developments in the industry. The Company's competitive position would be 
adversely affected if it were unable to anticipate such future developments 
and obtain access to the new technology.

DEPENDENCE ON KEY PERSONNEL; NEED TO RETAIN TECHNICAL PERSONNEL

The Company's success will depend to a large extent upon the continued 
contributions of Lon E. Bell, Ph.D., Chief Executive Officer, Chairman of the 
Board of Directors and the founder of the Company, and Richard A. Weisbart, 
President and Chief Operating Officer and a Director. The Company has 
obtained key-person life insurance coverage in the amount of $2,000,000 on 
the life of Dr. Bell. Neither Dr. Bell nor Mr. Weisbart is bound by an 
employment agreement with the Company. The loss of the services of Dr. Bell, 
Mr. Weisbart or any of the Company's executive personnel could materially 
adversely affect the Company. The success of the Company will also depend, in 
part, upon its ability to retain qualified engineering and other technical 
and marketing personnel. There is significant competition for technologically 
qualified personnel in the geographical area of the Company's business and 
the Company may not be successful in recruiting or retaining sufficient 
qualified personnel.

RELIANCE ON MAJOR CONTRACTORS; RISKS OF INTERNATIONAL OPERATIONS

The Company has in the past engaged certain outside contractors to perform 
product assembly and other production functions for the Company, and the 
Company anticipates that it may desire to engage contractors for such 
purposes in the future. The Company believes that there are a number of 
outside contractors that provide services of the kind that have been used by 
the Company in the past and that the Company may desire to use in the future. 
However, no assurance can be given that any such contractors would agree to 
work for the Company on terms acceptable to the Company or at all. The 
Company's inability to engage outside contractors on acceptable terms or at 
all would impair the Company's ability to complete any development and/or 
manufacturing contracts for which outside contractors' services may be 
needed. Moreover, the Company's reliance upon third party contractors for 
certain production functions will reduce the Company's control over the 
manufacture of its products and will make the Company dependent in part upon 
such third parties to deliver its products in a timely manner, with 
satisfactory quality controls and on a competitive basis.

Furthermore, the Company may engage contractors located in foreign countries. 
Accordingly, the Company will be subject to all of the risks inherent in 
international operations, including work stoppages, transportation delays and 
interruptions, political instability, foreign currency fluctuations, economic 
disruptions, the imposition of tariffs and import and export controls, 
changes in governmental policies and other factors which could have an 
adverse effect on the Company's business. See also "Risk of Foreign Sales."

POTENTIAL PRODUCT LIABILITY

The Company's business will expose it to potential product liability risks 
which are inherent in the manufacturing, marketing and sale of automotive 
components. In particular, there may be substantial warranty and liability 
risks associated with critical safety components of the Company's products. 
If available, product liability insurance generally is expensive. While the 
Company presently has $2,000,000 of product liability coverage, there can be 
no assurance that it will be able to obtain or maintain such insurance on 
acceptable terms with respect to other products the Company may develop, or 
that any insurance obtained will provide adequate protection against any 
potential liabilities when and if high volume production begins, the Company 
expects to purchase additional insurance coverage. In the event of a 
successful claim against the Company, a lack or insufficiency of insurance 
coverage could have a material adverse effect on the Company's business and 
operations.

NO DIVIDENDS

The Company has not paid any cash dividends on its Common Stock since its 
inception and, by reason of its present financial status and its contemplated 
financial requirements, does not anticipate paying any cash dividends in the 
foreseeable future. It is anticipated that significant additional financing 
will be necessary to fund the Company's long-term operations.

FLUCTUATIONS IN QUARTERLY RESULTS; POSSIBLE VOLATILITY OF STOCK PRICE

                                       13



Factors such as announcements by the Company of quarterly variations in its 
financial results, or unexpected losses, could cause the market price of the 
Class A Common Stock of the Company to fluctuate significantly. The results 
of operations in previous quarters have been partially dependent on large 
grants, orders and development contracts, which may not recur in the future. 
In addition, the Company's quarterly operating results may fluctuate 
significantly in the future due to a number of other factors, including 
timing of product introductions by the Company and its competitors, 
availability and pricing of components from third parties, timing of orders, 
foreign currency exchange rates, technological changes and economic 
conditions generally. Development contract revenues declined significantly 
because the activity on the Company's major electric vehicle development 
contract substantially concluded at the end of 1996 with no replacement 
contract presently scheduled to follow. See "Item 7 Management's Discussion 
and Analysis of Financial Condition and Results of Operations." In recent 
years, the stock markets in general, and the share prices of technology 
companies in particular, have experienced extreme fluctuations. These broad 
market and industry fluctuations may adversely affect the market price of the 
Class A Common Stock. In addition, failure to meet or exceed analysts' 
expectations of financial performance may result in immediate and significant 
price and volume fluctuations in the Class A Common Stock.

POTENTIAL CONFLICTS OF INTEREST

The Company leases its current facilities from Dillingham Partners, an entity 
that is 60% controlled by Dr. Bell. The Company determined that the lease is 
on terms no less favorable to the Company than those which could be obtained 
from unaffiliated parties.

John W. Clark, a director of the Company, is a partner of Westar Capital. 
Westar Capital is one of the two primary investors in the Proposed Financing. 
See "Item 7 Management Discussion and Analysis - Liquidity and Capital 
Resources." This transaction, combined with Mr. Clark's membership on the 
Board of Directors, could give rise to conflicts of interest.

In August 1998 the Board of Directors decided to suspend funding the electric 
vehicle program because it was generating continuing losses and utilizing 
resources that the Board felt would be better utilized by pursuit of the CCS 
and radar products. Dr. Bell agreed to fund the program personally, in return 
for a 15% interest in the EV Sub, which was transferred to Dr. Bell in March 
of 1999. In connection with the Proposed Financing, Dr. Bell may acquire the 
remaining equity interest in the EV Sub in exchange for the Class B Shares of 
the Company. This means that the Company may have no further ownership 
interest in electric vehicle technology and will only have the rights to EV 
Sub payment of 85% of the royalties which the EV Sub receives from the Indian 
JV. This transaction is subject to conditions, including shareholder 
approval. This transaction, combined with Dr. Bell's ownership of a 
significant percentage of the Company's Class A Common Stock, his position as 
an officer and his membership on the Board of Directors, could give rise to 
conflicts of interest.

ANTI-TAKEOVER EFFECTS OF PREFERRED STOCK

The Series A Preferred Stock proposed to be issued to the Investors in 
connection with the proposed financing will have the right to elect five of 
seven members of the Board of Directors. In addition, the Series A Preferred 
Stock will vote together with the shares of Class A Common Stock on any other 
matter submitted to shareholders. Immediately following the closing of the 
proposed financing, holders of the Series A Preferred Stock will have 
approximately 74% of the voting shares of the Company and will have the 
ability to approve or prevent any subsequent change in control of the Company.

In addition, the Company's Board of Directors has the authority to issue up 
to 5,000,000 shares of Preferred Stock and to determine the price, rights, 
preferences and privileges of those shares without any further vote or action 
by the shareholders. The rights of the holders of Class A Common Stock will 
be subject to, and may be adversely affected by, the rights of the holders of 
any shares of Preferred Stock that may be issued in the future. The issuance 
of Preferred Stock, while providing desirable flexibility in connection with 
possible acquisitions and other corporate purposes, could have the effect of 
making it more difficult for a third party to acquire a majority of the 
outstanding voting stock of the Company.

RISK OF FOREIGN SALES

A substantial percentage of the Company's revenues to date have been from 
sales to foreign countries. Accordingly, the Company's business is subject to 
many of the risks of international operations, including governmental 
controls, tariff restrictions, foreign currency fluctuations and currency 
control regulations. However, substantially all sales to foreign countries 
have been denominated in U.S. dollars. As such, the Company's historical net 
exposure to foreign currency fluctuations has not been material. No assurance 
can be given that future contracts will be denominated in U.S. dollars, 
however.

                                       14



ITEM 2.  PROPERTIES

The Company maintains its corporate headquarters, manufacturing and research 
and development facilities in leased space of approximately 40,000 square 
feet in Irwindale, California. The Company's lease expires December 31, 2002. 
The current monthly rent under the lease is approximately $20,000. The 
Company believes that its facilities are adequate for its present 
requirements. See "Item 1 -- Risk Factors - Potential Conflict of Interest."

ITEM 3.  LEGAL PROCEEDINGS

On November 14, 1996, Gibbins Pattern & Plastic, Inc. ("Gibbins"), a supplier 
to the Company, filed suit against the Company in Michigan state court in the 
circuit court for the County of Wayne, Michigan for breach of contract, open 
account/account stated, and unjust enrichment/quantum meruit. The Company 
settled the case out of court during 1998.

The Company is subject to litigation from time to time in the ordinary course 
of its business, but there is no current pending litigation to which the 
Company is a party.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On December 18, 1998 the Company filed a proxy statement with the Securities 
and Exchange Commission and began to solicit shareholder approval of an 
amendment to the Company's Articles of Incorporation which would effect a 
1-for-5 reverse stock split of the Company's Class A Common Stock and 
increase the effective amount of authorized but unissued Class A Common 
Stock. On January 25, 1999 the Company held a special shareholders meeting 
where the 1-for-5 reverse stock split was approved. 11,380,104 shares were 
voted in favor of the reverse stock split, 391,845 shares were voted against 
the reverse stock split, and 30,857 shares were not voted due to abstention 
or broker non-vote. The reverse stock split became effective on January 26, 
1999, upon the filing of an amendment to the Articles of Incorporation of the 
Company, and the Company's Class A Common Stock began trading on the adjusted 
basis on the Nasdaq SmallCap Market on January 28, 1999. Share information 
for all periods has been retroactively adjusted to reflect the split.

                                    PART II

ITEM 5.   MARKET FOR THE REGISTRANT'S COMMON STOCK AND RELATED STOCKHOLDER 
MATTERS

The Company's Class A Common Stock trades on the Nasdaq SmallCap Market under 
the symbol ARGNA. The Company's Class A Warrants trade on the Nasdaq SmallCap 
Market under the symbol ARGNW. The following table sets forth the high and 
low bid prices for the Class A Common Stock as reported on the Nasdaq 
SmallCap Market for each quarterly period (or part thereof) from the 
beginning of the first quarter of 1997 through December 31, 1998. Such prices 
reflect inter-dealer prices, without retail mark-up, markdown or commission 
and may not necessarily represent actual transactions.



1997                                        HIGH(1)   LOW(1)
                                            -------   ------
                                                
   1st Quarter.........................     $33.75    $17.50
   2nd Quarter.........................      25.65     12.50
   3rd Quarter.........................      35.00     18.75
   4th Quarter.........................      35.30     10.30
1998
   1st Quarter.........................      14.05      5.00
   2nd Quarter.........................       6.90      3.15
   3rd Quarter.........................       3.60      1.25
   4th Quarter.........................       5.00       .65



As of March 3, 1999, there were approximately 1,775 holders of record of the 
Class A Common Stock (not including beneficial owners holding shares in 
nominee accounts).

The Company has not paid any cash dividends since its formation and, given 
its present financial status and its anticipated financial requirements, does 
not expect to pay any cash dividends in the foreseeable future. The Company 
was prohibited during 1996 from paying cash dividends by the terms of its 
secured bank line of credit, which was paid off using a portion of the net 
proceeds of the Offering and terminated effective February 18, 1997.

                                       15



- -------------------

(1)    Numbers adjusted to give effect to the 1-for-5 reverse stock split that
       became effective on January 26, 1999, upon the filing of an amendment to
       the Articles of Incorporation of the Company. The Company's Class A
       Common Stock began trading on the adjusted basis on the Nasdaq SmallCap
       Market on January 28, 1999. See "Item 4 Submission of Matters to a Vote
       of Security Holders."

ITEM 6.  SELECTED FINANCIAL DATA



                                                                                         YEAR ENDED DECEMBER 31,
                                                                                          -----------------------
                                                                                  (IN THOUSANDS EXCEPT PER SHARE DATA)
                                                                     1994          1995         1996          1997          1998
                                                                     ----          ----         ----          ----          ----
                                                                                                           
        Total revenues..........................................   $  2,640     $  7,809      $  7,447      $  1,308      $   770
        Net loss................................................     (4,235)      (3,237)       (9,997)       (5,417)      (7,704)
        Net loss per diluted share (1) (2)......................      (6.40)       (4.90)       (12.30)        (3.10)       (4.03)
        Deficit accumulated during development stage............     (9,950)     (13,187)      (23,184)      (28,601)     (36,305)





                                                                                         AS OF DECEMBER 31,
                                                                                         -----------------
                                                                                           (IN THOUSANDS)
                                                                     1994          1995         1996          1997          1998
                                                                     ----          ----         ----          ----          ----
                                                                                                           
        Working capital.........................................   $  4,149      $ 6,481      $ (3,315)     $  8,826      $ 1,190
        Total assets............................................      7,162        8,995         3,922        10,568        2,644
        Capitalized lease obligations...........................         78           68            43            41           65



- -----------

(1)    Excluded from the average number of common shares used to calculate net
       loss per share are the 600,000 Escrowed Contingent Shares (See Note 7 to
       the Financial Statements). Adoption of SFAS No. 128 "Earnings Per Share"
       by the Company. No effect on previously reported per share information
       occurred due to antidilution provisions of the accounting principles.

(2)    Numbers adjusted to give effect to the 1-for-5 reverse stock split that
       became effective on January 26, 1999, upon the filing of an amendment to
       the Articles of Incorporation of the Company. The Company's Class A
       Common Stock began trading on the adjusted basis on the Nasdaq SmallCap
       Market on January 28, 1999. See "Item 4 Submission of Matters to a Vote
       of Security Holders."

ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS

The following discussion and analysis should be read in conjunction with the 
financial statements of the Company and related notes thereto appearing 
elsewhere in this report, and is qualified in its entirety by the same and by 
other more detailed financial information appearing elsewhere in this report.

OVERVIEW OF DEVELOPMENT STAGE ACTIVITIES

Historically, the Company's operations during the development stage have 
focused on the research and development of technologies to adapt them for a 
variety of uses in the automotive industry. Although the Company licensed the 
rights to these technologies from the holders of the related patents, it has 
now developed its own patented or patentable technology to complement those 
licenses. The Company recently lost the exclusivity on its license to certain 
radar technology from LLNL, but intends to continue to pursue radar products 
with its own technology In the automotive components industry, products 
typically proceed through five stages of research and development and 
commercialization. Initial research on the product 

                                       16



concept comes first, in order to assess its technical feasibility and 
economic costs and benefits, and often includes the development of an 
internal prototype for the supplier's own evaluation of the product. If the 
product appears feasible, a functioning prototype or demonstration prototype 
is manufactured by the component supplier to demonstrate and test the 
features of the product. This prototype is then marketed to automotive 
companies to generate sales of evaluation prototypes for internal evaluation 
by the automobile manufacturer. If the automobile manufacturer remains 
interested in the product after testing initial evaluation prototypes, it 
typically works with the component supplier to refine the product and then 
purchase second and subsequent generation engineering prototypes for further 
evaluation. Finally, the automobile manufacturer determines to either 
purchase the component for a production vehicle or terminate interest in the 
component. See "Item 1 Business Marketing and Sales."

As development of the Company's products proceeds, the Company seeks to 
generate revenues from the sale of prototypes, then from specific development 
contracts, pre-production orders and, ultimately, production orders. The 
Company received its first production order in December 1997 and during 1998 
the Company was selected to supply its CCS system to be installed in seat 
systems for one platform of a major North American auto manufacturer starting 
in the 2000 model year. The Company is continuing its efforts to obtain 
commitments and orders from large equipment manufacturers. Development 
contracts are from customers interested in developing a particular use or 
project using the Company's technologies and are generally longer term 
activities (from six months to one year) involving, in some cases, 
pre-production orders of larger quantities of the product for final testing 
by the customer before submitting a production order. Revenues have been 
obtained in the past as grant funding from government agencies interested in 
promoting the technologies for specific tasks or projects, as well as 
development funds from prototype sales to customers, help offset the 
development expenses overall.

The Company received no funds to offset its development expenses from any 
funding source in 1991 and, in 1992, secured its first outside grant totaling 
$1,900,000. In 1993, the Company sold $188,000 in prototypes of its 
developing technology adaptations and, in addition, recorded $2,101,000 in 
grant revenue. In 1994, the sale of prototypes increased and the Company 
recorded its first development contract revenues, increasing revenues from 
these sources to $1,336,000. Grant revenues became less important as a source 
of total revenues, decreasing in 1994 to 49% of total revenues from 92% in 
1993. In late 1994, the Company entered into the Samsung contract, from which 
revenues of $4,040,000, $5,328,000, and $533,000 were recorded in 1995, 1996 
and 1997, respectively. In addition, the Company recorded revenues from two 
grants related to the development of the electric vehicle technology in 1995 
and 1996 of $1,872,000 and $840,000, respectively. The Company's activity on 
the Samsung contract diminished during the fourth quarter of 1996 and 
substantially concluded at the end of the year. No replacement revenue was 
scheduled for 1997 or 1998. In addition, in 1996, the Company substantially 
completed work relating to the two electric vehicle grants, with no 
replacement grants scheduled to follow. As of December 31, 1998, the Company 
had no development contracts in place except for contracts to build prototype 
systems. The Company has no efforts to obtain any additional grants and has 
focused its efforts on working toward production contracts for Climate 
Control Seat ("CCS") systems and radar sensor systems. See "Item 1 Risk 
Factors Dependence on Grants; Government Audits of Grants."

RESULTS OF OPERATIONS YEAR ENDED DECEMBER 31, 1998 COMPARED TO YEAR ENDED 
DECEMBER 31, 1997

Total revenues for the year ended December 31, 1998 ("1998") decreased by 
$538,000, or approximately 41%, to $770,000, from $1,308,000 for the year 
ended December 31, 1997 ("1997"). The decline was primarily due to the 
completion of certain development contracts in 1997 and a reduced level of 
development contract activity in 1998.

During 1998, development continued on CCS and the Company's radar system, 
some of which was funded by development contracts. Development contract 
revenue relating to the Company's CCS and radar products decreased to 
$752,000 in 1998, a decline of $529,000, or approximately 41% from the 
$1,281,000 in such revenue recorded for 1997. The decrease in 1998 
principally reflects the Company's completion in 1997 of work on several 
development contracts. The Company is not seeking to obtain new grants and 
continues to focus its efforts on working toward production contracts for CCS 
and radar sensor systems.

Direct development contract and related grant costs decreased to $1,364,000 
in 1998 from $2,586,000 in 1997, primarily due to decreased activity in the 
Company's electric vehicle program in 1997 and the end of allocating 
administrative expenses to this category.

Research and development expenses increased by $1,130,000 or approximately 
55%, in 1998 to $3,202,000 from $2,072,000 in 1997. These expenses represent 
research and development expenses for which no development contract or grant 
funding has been obtained. The increase was due to an increase in headcount, 
tooling expenditures, prototype materials and consulting.

                                       17



Selling, general and administrative ("SG&A") expenses decreased by $373,000, 
or approximately 8%, in 1998 to $4,098,000 from $4,471,000 in 1997. The 
decrease in 1998 was primarily due to the reduction in salaries and wages 
related to reduced headcount and the nonrecurrence of costs related to IUS 
joint venture activities in 1997. 

Net interest income totaled $238,000 and $406,000 in 1998 and 1997, 
respectively. Interest income decreased due to a decline in cash balances as 
a result of those funds being used in operations.

RESULTS OF OPERATIONS YEAR ENDED DECEMBER 31, 1997 COMPARED TO YEAR ENDED 
DECEMBER 31, 1996

Total revenues for the year ended December 31, 1997 ("1997") decreased by 
$6,139,000, or approximately 82% to $1,308,000, from $7,447,000 for the year 
ended December 31, 1996 ("1996"). Approximately $533,000, or nearly 41% of 
1997 total revenues were derived from the Samsung contract and related 
grants, which is a decrease of approximately $5,635,000 when compared to 
1996, when $6,168,000, or nearly 83% of total revenues were related to the 
Samsung contract and other grants. The Company completed work on the Samsung 
contract and the related grants in 1997. No replacement contract or 
replacement grants are scheduled to follow or expected to be obtained.

During 1997, development continued on CCS and the Company's radar system, 
some of which was funded by development contracts. Development contract 
revenue relating to the Company's CCS, radar and IVS-TM- products decreased 
to $748,000 in 1997, a decline of $199,000, or approximately 21% from the 
$947,000 in such revenue recorded for 1996. The decrease in 1997 principally 
reflects the lack of commercial sales of IVS-TM- products as well as the 
Company's completion in 1996 of work on several development contracts 
relating to the IVS-TM- products not replaced in 1997 with new contracts. The 
Company began selling IVS-TM- products in 1995. The total revenue recognized 
for the IVS-TM- products in 1997 was $10,000, compared with $363,000 in 1996. 
On July 24, 1997, the Company entered into a joint venture agreement with 
Yazaki Corporation to form a new entity to develop and market the IVS-TM- 
products. Under the terms of the agreement, Yazaki Corporation owns a 
majority interest and the Company owns a minority interest of IVS, Inc. -TM-. 
As part of the transaction, the Company received $1,800,000 in cash and a 
note receivable for $1,000,000 in consideration for net assets related to 
Amerigon's voice interactive technology totaling approximately $89,000. In 
addition, the Company incurred costs of $348,000 associated with the sale. 
$1,800,000 was paid through July 1997 and $971,000 was paid in July 1998. 
Revenues from, grants other than electric vehicle-related grants decreased by 
$305,000, or approximately 92% to $27,000 in 1997 from $332,000 in 1996.

Revenue from electric vehicle development contracts decreased $5,183,000 or 
approximately 97% in 1997 to $145,000 from $5,328,000 in 1996. The Company 
completed the Samsung contract in 1997. Related electric vehicle grant 
revenues totaled $389,000 in 1997, a decrease of $451,000, or approximately 
54%, from the $840,000 in such revenues recorded for 1996. The reduction in 
these grant revenues reflects the completion of the Samsung contract as 
discussed above.

Direct development contract and related grant costs decreased to $2,586,000 
in 1997 from $11,533,000 in 1996, primarily due to decreased activity in the 
Company's electric vehicle program in 1997, particularly in connection with 
the Samsung contract and related grants. The Company also recorded changes to 
operations in 1996, included in the total direct development contract and 
related grant costs, for the ultimate estimated loss at completion of the 
contract of approximately $1,900,000. Direct development costs related to 
commercial sales of IVS-TM- decreased in 1997 to $55,000 from $490,000 in 
1996 primarily due to weak demand on IVS-TM- products and the sale of the 
Company's IVS-TM- technology to Yazaki Corporation.

Direct grant costs in 1997 declined by $185,000, or approximately 88%, to 
$25,000 from $210,000 in 1996. These costs are related to the projects for 
which grant revenues are reported. The decrease in 1997 reflects the decline 
in grant project activities in which the Company was engaged during 1997. 
Grant costs as a percentage of grant revenues of $27,000 and $332,000 were 
93% and 63% in 1997 and 1996, respectively.

Research and development expenses declined by $56,000, or approximately 3%, 
in 1997 to $2,072,000 from $2,128,000 in 1996. These expenses represent 
research and development expenses for which no development contract or grant 
funding has been obtained. Expenses of research and development projects that 
are specifically funded by development contracts from customers are 
classified under direct development contract and related grant costs or 
direct grant costs.

Selling, general and administrative ("SG&A") expenses increases by 
$1,061,000, or approximately 31%, in 1997 to $4,471,000 and development 
expenses from $3,410,000 in 1996. The increase in 1997 was primarily due to 
the fact that fewer SG&A expenses were allocated to development contracts. 
The Company also incurred costs related to the IVS-TM- joint venture and 
costs associated with locating strategic partners for the electric vehicle 
program. Direct and indirect overhead 

                                       18



expenses included in SG&A that are associated with development contracts are 
allocated to such contracts.

Interest expense incurred totaled $71,000 and $211,000 in 1997 and 1996, 
respectively. For 1997, interest expense represents charges incurred in 
conjunction with a bank line of credit obtained to finance work on the 
Samsung electric vehicle contract, the Bridge Financing, and the loan from 
the Company's Chief Executive Officer and principal shareholder. These loans 
were repaid upon the completion of the Company's Follow-on Public Offering in 
February 1997. Interest income increased to $477,000 in 1997 from $48,000 in 
1996 as a result of higher cash balances maintained in investments purchased 
during 1997 with proceeds from the Company's secondary offering. Net interest 
income (expense) was $406,000 in 1997 compared with ($163,000) in 1996. Also, 
the net loss of the Company was partially offset by the gain on disposal of 
assets due to the joint venture with Yazaki Corporation. See "Note 15."

LIQUIDITY AND CAPITAL RESOURCES

At December 31, 1998, the Company had working capital of $1,190,000. On March 
29, 1999 the Company entered into a Securities Purchase Agreement with Westar 
Capital LLC and Big Beaver Investments LLC (the "Investors") pursuant to 
which the Investors will invest $9 million in the Company in return for 9,000 
shares of Series A Preferred Stock which are convertible into Class A Common 
Stock and warrants that are exercisable only to the extent certain other 
warrants to purchase Class A Common Stock are exercised and then only in an 
amount that will enable the Investors to maintain the same percentage 
interest in the Company that they have in the Company after the initial 
investment on a fully converted basis. This transaction is subject to a 
number of conditions, including shareholder approval, which the Company 
intends to seek at the 1999 Annual Shareholders Meeting. Concurrent with the 
execution of the Securities Purchase Agreement, an affiliate of the Investors 
provided a secured bridge loan to the Company for up to $1.2 million which 
bears interest at 10% per annum and matures upon the earlier of September 30, 
1999 or the completion of the equity financing and contains detachable 
warrants for 300,000 shares of Class A Common Stock which will be cancelled 
upon the completion of the equity investment. The bridge loan is necessary to 
allow the Company to continue operations pending the closing of the equity 
financing, although the amount of the bridge loan may not be adequate even if 
fully drawn. Further, there are numerous conditions to making each borrowing 
under the bridge loan. No assurance can be given that the proposed financing 
will be completed. The Company's principal sources of operating capital have 
been the proceeds of its various financing transactions and, to a lesser 
extent, revenues from grants, development contracts and sale of prototypes to 
customers.

Cash and cash equivalents decreased by $4,370,000 in 1998 primarily due to a 
net loss of $7,704,000. Operating activities used $7,227,000, which was 
primarily a result of the net loss of $7,704,000 and repayment of $287,000 of 
outstanding balances to vendors, and reductions of deferred revenues of 
$53,000, reductions of accounts receivable of $60,000 and an increase in 
accrued liabilities of $164,000. Investing activities provided $2,922,000, of 
which $2,400,000 was from the selling of short-term investments along with 
$971,000 from a receivable from sale of assets, offset by $449,000 related to 
the purchase of property and equipment.  Financing activities used $65,000 
for repayment of capital leases.

The Company requires immediate financing and expects to incur losses for the 
foreseeable future due to the continuing cost of its product development and 
marketing activities. To fund its operations, the Company will need immediate 
financing from sources outside the Company before it can achieve 
profitability from its operations. While the Company has just secured a loan 
for up to $1.2 million and entered into an agreement for a $9 million equity 
investment as described above there can be no assurance that the proposed 
equity financing will be consummated or even if it is, that additional 
financing will not need to be obtained. The Company does not anticipate that 
the proceeds from the proposed financing will be sufficient to meet the 
Company's operating needs beyond a year. At or before that time, the Company 
will need additional financing or will be unable to continue operations. 
There is no assurance that additional financing can be secured. The Company's 
focus is to bring products to market and achieve revenues based upon its 
available resources. The Company continues to pursue the market introduction 
of its CCS and radar based sensor device, both for the automotive 
marketplace. If and when the Company is able to commence commercial volume 
production of its heated and cooled seat or radar products, the Company will 
incur significant expenses for tooling product parts and to set up 
manufacturing and/or assembly processes. The Company also expects to require 
significant capital to fund other near-term production engineering and 
manufacturing, as well as research and development and marketing, of these 
products. The Company does not intend to pursue any more significant grants 
or development contracts to fund operations and therefore is highly dependent 
on its current working capital sources. Should the Company not obtain 
additional equity and/or debt financing immediately, the Company will be 
required to significantly curtail its development activities, dispose of one 
or more of its technologies and/or cease operations and liquidate. There can 
be no assurance that either of these sources is available.

YEAR 2000 IMPACT

                                       19



An issue affecting Amerigon and others is the ability of many computer 
systems and applications to process the Year 2000 and beyond ("Y2K"). To 
address this problem, in 1998, Amerigon initiated a Y2K program to manage the 
Company's overall Y2K compliance effort. A team of internal staff is managing 
the program with assistance of some outside consultants. The team's 
activities are designed to ensure that there are no material adverse effects 
on the Company.

The Company is in the assessment phase of its internal information services 
computer systems associated with the Year 2000. The Company is currently 
assessing Year 2000 issues related to its non-information technology systems 
used in product development, engineering, manufacturing and facilities.

The Company is also working with its significant suppliers and financial 
institutions to ensure that those parties have appropriate plans to address 
Y2K issues where their systems interface with the Company's systems or 
otherwise impact its operations. The Company has communicated in writing with 
all of its principal suppliers to confirm their status in regards to Y2K 
issues. The Company is assessing the extent to which its operations are 
vulnerable should those organizations fail to properly remedy their computer 
systems. The Company does not anticipate that potential Year 2000 issues at 
the customer level will have a material adverse effect on its ability to 
conduct normal business.

The Company's Y2K program is well under way and, based on the results of its 
assessment to date is expected to be complete by mid-1999. While the Company 
believes its planning efforts are adequate to address its Year 2000 concerns, 
there can be no assurance that the systems of other companies on which the 
Company's systems and operations rely will be converted on a timely basis and 
will not have a material adverse effect on the Company. The Company has not 
identified a need to develop an extensive contingency plan for 
non-remediation issues at this time. The need for such a plan is evaluated on 
an ongoing basis as part of the Company's overall Year 2000 initiative.

Based on the Company's assessment to date, the costs of the Year 2000 
initiative (which are expensed as incurred) are estimate to be approximately 
$20,000.

The cost of the project and the date on which the Company believes it will 
complete its Year 2000 initiative are forward-looking statements and are 
based on management's best estimate, according to information available 
through the Company's assessments to date. However, there can be no assurance 
that these estimates will be achieved, and actual results could differ 
materially from those anticipated. Specific factors that might cause such 
material differences include, but are not limited to, the availability and 
cost of personnel trained in this area, the retention of these professions, 
the ability to locate and correct all relevant computer codes, and similar 
uncertainties. At present, the Company has not experienced any significant 
problems in these areas.

ITEM 7A.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company's investment portfolio consists of cash equivalents with no 
significant market risk. The Company places its investments in debt 
instruments of the U. S. government and in high-quality corporate issuers. As 
stated in its policy, the Company seeks to ensure the safety and preservation 
of its invested funds by limiting default risk and market risk. The Company 
has no investments denominated in foreign country currencies and therefore is 
not subject to foreign exchange risk.

ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements and related financial information required to be 
filed hereunder are indexed on page F-1 of this report and are incorporated 
herein by reference.

                                       20



ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND 
FINANCIAL DISCLOSURE

None

                                    PART III

ITEM 10.  DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

The information required by this item is incorporated by reference from the 
information contained under the captions entitled "Election of Directors," 
"Executive Officers" and "Section 16(a) Beneficial Ownership Reporting 
Compliance" in the Company's definitive proxy statement to be filed with the 
Commission in connection with the Company's 1999 Annual Meeting of 
Stockholders.

ITEM 11.  EXECUTIVE COMPENSATION

The information required by this item is incorporated by reference from the 
information contained under the captions entitled "Executive Compensation," 
"Executive Compensation Table," "Report of the Compensation Committee on 
Executive Compensation," "Compensation Committee Interlocks and Insider 
Participation," "Option Grant Table," "Aggregate Options Exercised and 
Year-End Values," and "Performance Graph" in the Company's definitive proxy 
statement to be filed with the Commission in connection with the Company's 
1999 Annual Meeting of Stockholders.

ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The information required by this item is incorporated by reference from the 
information contained under the caption entitled "Security Ownership of 
Certain Beneficial Owners and Management" and "Escrow Shares" in the 
Company's definitive proxy statement to be filed with the Commission in 
connection with the Company's 1999 Annual Meeting of Stockholders.

ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

The information required by this item is incorporated by reference from the 
information contained under the caption entitled "Certain Transactions" in 
the Company's definitive proxy statement to be filed with the Commission in 
connection with the Company's 1999 Annual Meeting of Stockholders.

                                     PART IV

ITEM 14.  EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K

(a)      The following documents are filed as part of this report:

         1.       Financial Statements.

                  The following financial statements of the Company and report
                  of independent accountants are included in Item 8 of this
                  Annual Report:



                                                                      Page
                                                                      ----
                                                                   
                  Report of Independent Accountants                    F-2
                  Balance Sheets                                       F-3
                  Statements of Operations                             F-4
                  Statements of Shareholders' Equity                   F-5
                  Statements of Cash Flows                             F-6
                  Notes to Financial Statements.                       F-7



         2.       Financial Statement Schedule.

                  The following Schedule to Financial Statements is included
                  herein:

                  Schedule II-- Valuation and Qualifying Accounts, together with
                  the report of independent accountants thereon.

         3.       Exhibits.

                                       21



                  The following exhibits are filed as a part of this report:



EXHIBIT
NUMBER                                      DESCRIPTION
- -------                                     -----------
             
 3.1.1          Amended and Restated Articles of Incorporation (the "Articles")
                of the Company (1)
 3.1.2          Certificate of Amendment of Articles filed with the California
                Secretary of State on December 5, 1996 (3)
 3.1.3          Certificate of Amendment of Articles filed with the California
                Secretary of State on January 26, 1999
 3.2            Amended and Restated Bylaws of the Company (3)
 4.1.1          Form of Warrant Agreement among the Company, the Underwriter and
                U.S. Stock Transfer Corporation as Warrant Agent (3)
 4.2            Form of Warrant Certificate for Class A Warrant (3)
 4.3            Form of Specimen Certificate of Company's Class A Common Stock (1)
 4.4            Escrow Agreement among the Company, U.S. Stock Transfer
                Corporation and the shareholders named therein (1)
10.1            1993 Stock Option Plan, together with Form of Incentive Stock
                Option Agreement and Nonqualified Stock Option Agreement (1)
10.4            Form of Underwriter's Unit Purchase Option (3)
10.5.1          Stock Option Agreement ("Bell Stock Option Agreement"),
                effective May 13, 1993, between Lon E. Bell and Roy A. Anderson (3)
10.5.2          List of omitted Bell Stock Option Agreements with Company directors (3)
10.6            Form of Indemnity Agreement between the Company and each of its
                officers and directors (1)
10.7            License Agreement, dated as of January 20, 1994, by and between
                the Company and the Regents of the University of California,
                together with a letter from the Regents to the Company dated
                September 19, 1996 relating thereto (3)**
10.7.1          Termination of Limited Exclusive License Agreement dated as of
                June 1998 between the Company and the Regents of the University
                of California
10.7.2          Limited Nonexclusive License Agreement dated as of June 1998
                between the Company and the Regents of the University of
                California
10.8            Option and License Agreement dated as of November 2, 1992
                between the Company and Feher Design, Inc. (1)
10.9            Shareholders Agreement, dated May 13, 1993, by and among the
                Company and the shareholders named therein (1)
10.10           Stock Purchase Agreement and Registration Rights Agreement
                between the Company and Fidelity Copernicus Fund, L.P. and
                Fidelity Galileo Fund, L.P., dated December 29, 1995 (2)
10.11           Stock Purchase Agreement and Registration Rights Agreement
                between the Company and HBI Financial Inc., dated December 29, 1995 (2)
10.13           Joint Venture Agreement between Yazaki Corporation and Amerigon
                Incorporated, dated July 22, 1997 (5)
10.14           Amendment to Option and License Agreement between Amerigon and
                Feher Design dated September 1, 1997 (6)
10.15           Standard Lease dated January 1, 1998 between Amerigon and
                Dillingham Partners (6)
10.16           Letter Agreement dated December 16, 1998 between the Company and
                Sudarshan K. Maini
10.17           Securities Purchase Agreement dated March 29, 1999 by and among
                the Company, Westar Capital II LLC and Big Beaver Investments LLC
10.18           Credit Agreement dated March 29, 1999 between the Company and
                Big Star Investments LLC
10.19           Security Agreement dated March 29, 1999 between the Company and
                Big Star Investments LLC
10.20           Patent and Trademark Security Agreement dated March 29, 1999
                between the Company and Big Star Investments LLC
10.21           Bridge Warrant dated March 29, 1999
10.22           Share Exchange Agreement dated March 29, 1999 between the
                Company and Lon E. Bell
21              List of Subsidiaries
23.1            Consent of Price Waterhouse LLP
23.2            Consent of Price Waterhouse LLP
27              Financial Data Schedule



     (b)     Reports on Form 8-K.

             During the quarter ended December 31, 1998, the Company filed no
             Current Reports on Form 8-K.

- -------------------

     (1)     Previously filed as an exhibit to the Company's Registration
             Statement on Form SB-2, as amended, File No. 33-61702-LA, and
             incorporated by reference.

                                       22



(2)      Previously filed as an exhibit to the Company's Current Report on Form
         8-K filed January 5, 1996 and incorporated by reference.

(3)      Previously filed as an exhibit to the Company Registration Statement on
         Form S-2, as amended, File No. 333-17401, and incorporated by
         reference.

(4)      Previously filed as an exhibit to the Company's Current Report on Form
         8-K, event date June 16, 1997, and incorporated herein by reference.

(5)      Previously filed as an exhibit to the Company's Current Report on Form
         8-K, event date July 22, 1997, and incorporated herein by reference.

(6)      Previously filed as an exhibit to the Company's Current Report on Form
         10-K for the period ended December 31, 1997, and incorporated herein by
         reference.

                                       23



                          INDEX TO FINANCIAL STATEMENTS



                                                                        PAGE
                                                                        ----
                                                                     
Report of Independent Accountants...................................     F-2
Balance Sheets......................................................     F-3
Statements of Operations............................................     F-4
Statements of Shareholders' Equity..................................     F-5
Statements of Cash Flows............................................     F-6
Notes to Financial Statements.......................................     F-7




                                       F-1



                        REPORT OF INDEPENDENT ACCOUNTANTS

To the Board of Directors and Shareholders of
Amerigon Incorporated (a Development Stage Enterprise)

In our opinion, the financial statements listed in the index appearing under 
Item(a)(1) and (2) present fairly, in all material respects, the financial 
position of Amerigon Incorporated (a Development Stage Enterprise) at 
December 31, 1997 and 1998, and the results of its operations and its cash 
flows for each of the three years in the period ended December 31, 1998, and 
for the period from April 23, 1991 (inception) to December 31, 1998, in 
conformity with generally accepted accounting principles. These financial 
statements are the responsibility of the Company's management; our 
responsibility is to express an opinion on these financial statements based 
on our audits. We conducted our audits of these statements in accordance with 
generally accepted auditing standards which require that we plan and perform 
the audit to obtain reasonable assurance about whether the financial 
statements are free of material misstatement. An audit includes examining, on 
a test basis, evidence supporting the amounts and disclosures in the 
financial statements, assessing the accounting principles used and 
significant estimates made by management, and evaluating the overall 
financial statement presentation. We believe that our audits provide a 
reasonable basis for the opinion expressed above.

The accompanying financial statements have been prepared assuming that the 
Company will continue as a going concern. As discussed in Note 2 to the 
financial statements, the Company has suffered recurring losses and negative 
cash flows from operations and has a significant accumulated deficit. These 
factors raise substantial doubt about the Company's ability to continue as a 
going concern. Management's plans in regard to these matters are also 
described in Note 2. The accompanying financial statements do not include any 
adjustments that might result from the outcome of this uncertainty.


PRICEWATERHOUSECOOPERS LLP

Costa Mesa, California
March 23, 1999

                                       F-2



                              AMERIGON INCORPORATED
                        (A DEVELOPMENT STAGE ENTERPRISE)

                                  BALANCE SHEET

                                 (IN THOUSANDS)

                                     ASSETS



                                                                                                             DECEMBER 31,
                                                                                                      -------------------------
                                                                                                          1997           1998
                                                                                                      -----------     ---------
                                                                                                                
Current assets:
   Cash and cash equivalents.......................................................................   $    6,037      $  1,667
    Short-term investments.........................................................................        2,400             -
   Accounts receivable less allowance of $80 in 1997 and $101 in 1998..............................          255           174
    Receivable due from joint venture partner (Note 15) ...........................................        1,000             -
   Inventory, primarily raw materials..............................................................           35           105
   Prepaid expenses and other current assets.......................................................          196           136
                                                                                                      -----------     ---------
      Total current assets.........................................................................        9,923         2,082

Property and equipment, net (Note 4)...............................................................          645           562
                                                                                                      -----------     ---------
      Total assets.................................................................................   $   10,568      $  2,644
                                                                                                      -----------     ---------
                                                                                                      -----------     ---------

                      LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
   Accounts payable.................................................................................   $     650      $    363
   Deferred revenue.................................................................................          97            44
   Accrued liabilities (Note 4).....................................................................         350           485
                                                                                                      -----------     ---------
      Total current liabilities.....................................................................       1,097           892

Long-term portion of capital lease (Note 13)........................................................          41            26

Commitments and contingencies (Notes 10 and 13) 
Shareholders' equity: (Notes 7, 8 and 9)
Preferred stock, no par value; 1,000 shares authorized, none issued and
outstanding Common stock:
   Class A - no par value; 8,000 shares authorized, 1,910 issued and outstanding
      in 1997 and 1998 (additional 600 shares held in escrow).......................................      28,149        28,149
                                                                                                          
   Class B - no par value, 600 shares authorized, none issued and outstanding.......................
   Contributed capital..............................................................................       9,882         9,882
                                                                                                          
   Deficit accumulated during development stage.....................................................     (28,601)      (36,305)
                                                                                                      -----------     ---------
      Total shareholders' equity ...................................................................       9,430         1,726
                                                                                                      -----------     ---------
      Total liabilities and shareholders' equity....................................................  $   10,568      $  2,644
                                                                                                      -----------     ---------
                                                                                                      -----------     ---------



              See accompanying notes to the financial statements.

                                       F-3



                                AMERIGON INCORPORATED

                           (A DEVELOPMENT STAGE ENTERPRISE)

                                 STATEMENT OF OPERATIONS

                         (IN THOUSANDS EXCEPT PER SHARE DATA)



                                                                                                     FROM
                                                                                                   APRIL 23,
                                                                                                     1991
                                                                                                  (INCEPTION)
                                                                                                      TO
                                                                 YEAR ENDED DECEMBER 31,          DECEMBER 31,
                                                           ----------------------------------     -----------
                                                             1996         1997         1998          1998
                                                           --------     --------     --------     -----------
                                                                                      
Revenues:
   Product .............................................   $      -     $      -     $     18     $      18
   Development contracts and related grants.............      7,115        1,281          752        17,962
   Grants...............................................        332           27            -         6,183
                                                           --------     --------     --------     ---------
      Total revenues....................................      7,447        1,308          770        24,163
                                                           --------     --------     --------     ---------
Costs and expenses:
   Product .............................................   $      -            -           48     $      48
   Direct development contract and related grant costs..     11,533        2,586        1,364        22,268
   Direct grant costs...................................        210           25            -         4,757
   Research and development.............................      2,128        2,072        3,202        14,061
   Selling, general and administrative, including
      reimbursable administrative costs.................      3,410        4,471        4,098        22,356
                                                           --------     --------     --------     ---------
      Total costs and expenses..........................     17,281        9,154        8,712        63,490
                                                           --------     --------     --------     ---------

Operating loss..........................................     (9,834)      (7,846)      (7,942)      (39,327)
Interest income.........................................         48          477          255         1,298
Interest expense........................................       (211)         (71)         (17)         (299)
Gain on disposal of assets .............................          -        2,363            -         2,363
                                                           --------     --------     --------     ---------

Operating loss before extraordinary item................     (9,997)      (5,077)      (7,704)      (35,965)
Extraordinary loss from extinguishment of indebtedness..          -         (340)           -          (340)
                                                           --------     --------     --------     ---------
Net loss................................................   $ (9,997)    $ (5,417)    $ (7,704)    $ (36,305)
                                                           --------     --------     --------     ---------
                                                           --------     --------     --------     ---------
Based and diluted net loss per share before
   extraordinary item...................................   $ (12.31)    $  (2.88)    $  (4.03)
Base and diluted net loss per share.....................   $ (12.31)    $  (3.08)    $  (4.03)
                                                           --------     --------     -------- 
                                                           --------     --------     -------- 
Weighted average number of shares outstanding...........        812        1,758        1,910
                                                           --------     --------     -------- 
                                                           --------     --------     -------- 



              See accompanying notes to the financial statements.

                                       F-4



                                AMERIGON INCORPORATED

                          (A DEVELOPMENT STAGE ENTERPRISE)

                         STATEMENT OF SHAREHOLDERS' EQUITY

                                  (IN THOUSANDS)



                                                                                                                 Deficit
                                                 Preferred                  Common Stock                         Accum.
                                                   Stock             Class A            Class B                  During
                                               ---------------   ---------------     ---------------   Contrib.  Devel.
                                               Shares   Amount   Shares   Amount     Shares   Amount   Capital    Stage      Total
                                               ------   ------   ------   ------     ------   ------   -------   --------   -------
                                                                                                
Balance at April 23, 1991 (Inception).......      -     $  -       200    $   100       -     $  -     $  -     $    -      $   100
  Contributed capital-founders' services
    provided without  compensation....            -        -       -          -         -        -        111        -          111
  Net loss...............................         -        -       -          -         -        -         -        (616)      (616)
                                               ----     ----     -----    -------     ---     ----     ------    -------    -------
Balance at December 31, 1991................      -        -       200        100       -        -        111       (616)      (405)
  Transfer of common stock to employee by
    principal shareholder for services......      -        -       -          -         -        -        150        -          150
  Contributed capital-founders' services
    provided without compensation...........      -        -       -          -         -        -        189        -          189
  Net loss..................................      -        -       -          -         -        -        -       (1,459)    (1,459)
                                               ----     ----     -----    -------     ---     ----     ------    -------    -------
Balance at December 31, 1992................      -        -       200        100       -        -        450     (2,075)    (1,525)
  Issuance of common stock (public 
    offering)...............................      -        -       460     11,534       -        -        -          -       11,534
  Options granted by principal shareholder 
    for services............................      -        -       -          -         -        -        549        -          549
  Contribution of notes payable to 
    contributed capital.....................      -        -       -          -         -        -      2,102        -        2,102
  Net loss..................................      -        -       -          -         -        -        -       (3,640)    (3,640)
                                               ----     ----     -----    -------     ---     ----     ------    -------    -------
Balance at December 31, 1993................      -        -       660     11,634       -        -      3,101     (5,715)     9,020
  Compensation recorded for variable 
    plan stock option.......................      -        -       -          -         -        -          1        -            1
  Net loss..................................      -        -       -          -         -        -        -       (4,235)    (4,235)
                                               ----     ----     -----    -------     ---     ----     ------    -------    -------
Balance at December 31, 1994................      -        -       660     11,634       -        -      3,102     (9,950)     4,786
  Private placement of common stock.........      -        -       150      5,636       -        -          1        -        5,637
  Compensation recorded for variable
    plan stock option ......................      -        -       -          -         -        -         12        -           12
  Net loss..................................      -        -       -          -         -        -        -       (3,237)    (3,237)
                                               ----     ----     -----    -------     ---     ----     ------    -------    -------
Balance at December 31, 1995................      -        -       810     17,270       -        -      3,115    (13,187)     7,198
  Exercise of stock options.................      -        -         4        160       -        -        -          -          160
  Repurchase of common stock................      -        -       -          (15)      -        -        -          -          (15)
  Expenses of sale of stock.................      -        -       -          (94)      -        -        -          -          (94)
  Net loss..................................      -        -       -          -         -        -        -       (9,997)    (9,997)
                                               ----     ----     -----    -------     ---     ----     ------    -------    -------
Balance at December 31, 1996................      -        -       814     17,321       -        -      3,115    (23,184)    (2,748)
  Issuance of common stock (public 
    offering)...............................      -        -     1,096     10,828       -        -      6,617         -      17,445
  Conversion of Bridge Debentures into
    Class A Warrants........................      -        -       -          -         -        -        150         -         150
  Net loss..................................      -        -       -          -         -        -        -       (5,417)    (5,417)
                                               ----     ----     -----    -------     ---     ----     ------    -------    -------
Balance at December 31, 1997................      -        -     1,910     28,149       -        -      9,882    (28,601)     9,430
  Net loss .................................      -        -       -          -         -        -        -       (7,704)    (7,704)
                                               ----     ----     -----    -------     ---     ----     ------    -------    -------
Balance at December 31, 1998................      -     $  -     1,910    $28,149       -     $  -     $9,882   $(36,305)   $ 1,726
                                               ----     ----     -----    -------     ---     ----     ------    -------    -------



              See accompanying notes to the financial statements.

                                       F-5



                               AMERIGON INCORPORATED

                           (A DEVELOPMENT STAGE ENTERPRISE)

                               STATEMENT OF CASH FLOWS

                                     (IN THOUSANDS)



                                                                                                             FROM
                                                                                                         APRIL 23,1991
                                                                                                         (INCEPTION) TO
                                                                       YEAR ENDED DECEMBER 31,           DECEMBER 31,
                                                               -------------------------------------     --------------
                                                                  1996          1997          1998           1998
                                                               ---------     ---------     ---------     --------------
                                                                                             
Operating activities:
   Net loss.................................................   $ (9,997)     $ (5,417)     $ (7,704)     $ (36,305)
   Adjustments to reconcile net loss to net cash used
      in operating activities:
      Depreciation and amortization.........................        357           162           582          1,656  
      Provision for doubtful accounts.......................         80             -            21            211  
      Stock option compensation.............................          -             -             -            712  
      Gain from sale of assets..............................          -        (2,363)            -         (2,363) 
      Contributed capital-founders' services provided                                                               
        without cash compensation...........................          -             -             -            300  
      Change in operating assets and liabilities:                                                                  
        Accounts receivable.................................       (216)          933            60           (385)  
        Unbilled revenue....................................        311         1,157             -              -  
        Inventory...........................................        223           (35)          (70)          (125) 
        Prepaid expenses and other current assets...........        217           548            60           (136)  
        Accounts payable....................................        444        (1,265)         (287)            15  
        Deferred revenue....................................         60           (57)          (53)            44 
        Accrued liabilities.................................          7          (133)          164            550 
                                                               --------      --------      --------      ---------
      Net cash used in operating activities.................     (8,514)       (6,470)       (7,227)       (35,826)
                                                               --------      --------      --------      ---------
Investing activities:
       Purchase of property and equipment...................       (182)         (302)         (449)        (2,195)
       Proceeds from sale of assets.........................          -         2,800             -          2,800
       Receivable from sales of assets......................          -        (1,000)            -         (1,000)
       Proceeds from receivable from sale of assets.........          -             -           971            971
       Short term investments...............................          -        (2,400)        2,400              -
                                                               --------      --------      --------      ---------
       Net cash provided by (used in) investing activities..       (182)         (902)        2,922            576
                                                               --------      --------      --------      ---------
Financing activities:
       Proceeds from sale of common stock, net..............        (94)       17,595             -         34,772
       Proceeds from exercise of stock options..............        160             -             -            160
       Repurchase of common stock...........................        (15)            -             -            (15)
       Borrowing under line of credit.......................      5,180             -             -          6,280
       Repayment of line of credit..........................     (3,993)       (1,187)            -         (6,280)
       Repayment of capital lease...........................        (25)           (2)          (65)          (102)
       Proceeds from Bridge Financing ......................      3,000             -             -          3,000
       Repayment of Bridge Financing........................          -        (3,000)            -         (3,000)
       Proceeds from note payable to shareholder............        200           250             -            450
       Repayment of note payable to shareholder.............          -          (450)            -           (450)
       Contributed to capital...............................          -             -             -          2,102
                                                               --------      --------      --------      ---------
       Net cash provided by (used in) financing activities..      4,413        13,206           (65)        36,917
                                                               --------      --------      --------      ---------
       Net increase (decrease) in cash and cash equivalents.     (4,283)        5,834        (4,370)         1,667
       Cash and cash equivalents at beginning of period.....      4,486           203         6,037              -
                                                               --------      --------      --------      ---------
       Cash and cash equivalents at end of period...........   $    203      $  6,037      $  1,667      $   1,667
                                                               --------      --------      --------      ---------
                                                               --------      --------      --------      ---------



              See accompanying notes to the financial statements.

                                       F-6



NOTE 1 -- THE COMPANY

Amerigon Incorporated (the "Company" or "Amerigon") is a development stage 
enterprise, which was incorporated in California on April 23, 1991, primarily 
to develop, manufacture and market proprietary, high technology automotive 
components and systems for gasoline-powered and electric vehicles.

Amerigon's activities through December 31, 1998, include (1) obtaining the 
rights to the basic technology underlying the climate control seat system, 
certain radar applications and the interactive voice navigation system; (2) 
obtaining financing from grants and other sources and conducting development 
programs related to electric vehicles and its other products; (3) marketing 
of these development stage products to automotive companies and their 
suppliers; (4) completing the development, in December 1995, of the audio 
navigation system; and (5) completing the development in April 1998, of the 
climate control seats and selling of the first commercial units. Amerigon 
completed a joint venture for its interactive navigation system (Note 15), 
and plans to focus continuing development activities on its Climate Control 
Seat and radar systems. The Company is in the process of formalizing a joint 
venture for its electric vehicle systems.

The Company augmented the expenditure of its own funds on research and 
development by seeking and obtaining various grants and contracts with 
potential customers which support the development of its products and related 
technologies.

NOTE 2 -- BASIS OF PRESENTATION

BASIS OF PRESENTATION

The Company has suffered recurring losses and negative cash flows from 
operations since inception and has a significant accumulated deficit. 
Consequently, in order to fund continuing operations and complete product 
development, the Company will need to raise additional financing. In this 
regard, on March 23, 1999, the Board of Directors approved a proposed 
financing transaction with an investor group to raise additional equity 
financing and obtain a bridge loan (Note 17). The equity financing, as 
currently contemplated, will require shareholder approval. Management 
believes that the proceeds from the equity financing and bridge loan will be 
sufficient to meet the Company's projected working capital needs through at 
least the end of 1999. The outcome of such efforts to raise working capital 
cannot be assured. As such, there is substantial doubt about the Company's 
ability to continue as a going concern.

The Company's financial statements have been prepared on the basis of 
accounting principles applicable to a going concern. Accordingly, they do not 
include any adjustments relating to the recoverability of the carrying amount 
of recorded assets or the amount of liabilities that might result from the 
outcome of these uncertainties.

NOTE 3 -- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

DISCLOSURES ABOUT FAIR VALUE OF FINANCIAL INSTRUMENTS

The carrying amount of all financial instruments, comprising cash and cash 
equivalents, accounts receivable, accounts payable, accrued expenses and 
capital leases, approximate fair value because of the short maturities of 
these instruments.

USE OF ESTIMATES

The presentation of financial statements in conformity with generally 
accepted accounting principles requires management to make estimates and 
assumptions that affect the reported amounts of assets and liabilities and 
disclosure of contingent assets and liabilities at the date of the financial 
statements and the reported amounts of revenues and expenses during the 
reporting period. Actual results could differ from those estimates.

STATEMENT OF CASH FLOWS

All investments with original maturities of less than 90 days are considered 
cash equivalents. Cash paid for interest totaled $211,000, $71,000 and 
$17,000 in 1996, 1997 and 1998, respectively. Capital lease obligations 
incurred totaled $0, $23,000 and $50,000 in 1996, 1997 and 1998, respectively.

                                       F-7



CONCENTRATION OF CREDIT RISK

Financial instruments which subject the Company to concentration of credit 
risk consist primarily of cash equivalents and accounts receivable. Cash 
equivalents are invested in the U. S. Treasury securities and money market 
account of a major U.S. financial services company and the risk is considered 
limited. The risk associated with accounts receivable is limited by the large 
size and creditworthiness of the Company's commercial customers and the 
federal and California government agencies providing grant funding.

INVESTMENTS

As of December 31, 1997, short-term investments to be held to maturity 
included U. S. Treasury securities of $1,414,000 and commercial paper of 
$986,000 with scheduled maturities of less than one year. The amortized cost, 
which includes accrued interest, approximates fair value.

INVENTORY

Inventory, other than inventoried purchases relating to development 
contracts, is valued at the lower of cost, based on the first-in, first-out 
basis, or market. Inventory related to development contracts is stated at 
cost, and is removed from inventory when used in the development project.

PROPERTY AND EQUIPMENT

Property and equipment, including additions and improvements, are recorded at 
cost. Expenditures for repairs and maintenance are charged to expense as 
incurred. When property or equipment is retired or otherwise disposed of, the 
related cost and accumulated depreciation are removed from the accounts. 
Gains or losses from retirements and disposals are recorded as other income 
or expense. Long-lived assets to be held and used are reviewed for impairment 
whenever events or changes in circumstances indicate that the related 
carrying amount may not be recoverable. Management does not believe that 
there are any material impairments at December 31, 1997 and 1998.

Property and equipment are depreciated over their estimated useful lives 
ranging from three to five years. Leasehold improvements are amortized over 
the shorter of their estimated useful lives or the term of the lease. 
Depreciation and amortization are computed using the straight-line method.

DEVELOPMENT CONTRACT REVENUES

The Company has had a series of fixed-price development contracts, which 
included (1) specific engineering and tooling services to prepare the 
Company's products and the related manufacturing processes for commercial 
sales to certain original equipment manufacturers ("OEMs"); (2) the 
development of complete electric vehicle systems (Note 11); and (3) prototype 
products developed during the research and development process, some of which 
are sold to third parties for evaluation purposes. Revenue is recognized on 
development contracts using the percentage of completion method or, in the 
case of short duration contracts, when the prototype or service is delivered. 
Revenues earned are recorded on the balance sheet as Unbilled Revenue until 
billed. All amounts received from customers in advance of the development 
effort are reflected on the balance sheet as Deferred Revenue until such time 
as the contracted work is performed.

GRANT REVENUES

Revenue from government agency grants and other sources pursuant to cost 
reimbursement and cost-sharing arrangements (Note 12) is recognized when 
reimbursable costs have been incurred. Billings on the Company's grant 
programs are generally subject to the Company achieving certain milestones or 
complying with billing schedules designated in the grant agreements. 
Accordingly, delays between the time reimbursable grant costs are incurred 
and then ultimately billed may occur. Grant revenues earned are recorded on 
the balance sheet as Unbilled Revenue until billed.

RESEARCH AND DEVELOPMENT EXPENSES

Research and development activities are expensed as incurred. These amounts 
represent direct expenses for wages, materials and services associated with 
development contracts, grant program activities and the development of the 
Company's products. Research and development expenses associated with 
projects that are specifically funded by development contracts or 

                                       F-8



grant agreements from customers are classified under Direct Development 
Contract and Related Grant Costs or Direct Grant Costs in the Statement of 
Operations. All other research and development expenses that are not 
associated with projects that are not specifically funded by development 
contracts or grants from customers are classified under Research and 
Development. Research and development excludes any overhead or administrative 
costs.

ACCOUNTING FOR STOCK-BASED COMPENSATION

The Company accounts for employee stock based compensation in accordance with 
Accounting Principles Board Opinion No. 25 and related interpretations. The 
disclosures required by Statement of Financial Accounting Standards No. 123, 
"Accounting for Stock-Based Compensation" ("SFAS 123"), have been included in 
Note 9.

INCOME TAXES

Income taxes are determined under guidelines prescribed by Financial 
Accounting Standards Board Statement No. 109 ("SFAS 109"), "Accounting for 
Income Taxes." Under the liability method specified by SFAS 109, deferred tax 
assets and liabilities are measured each year based on the difference between 
the financial statement and tax bases of assets and liabilities at the 
applicable enacted federal and state tax rates. A valuation allowance is 
provided for the portion of net deferred tax assets considered unlikely to be 
realized (Note 5).

NET LOSS PER SHARE

Under the provisions of SFAS 128, "Earnings per Share," basic earnings per 
share ("Basic EPS") is computed by dividing net loss available to common 
shareholders by the weighted average number of common shares outstanding 
during the period. Diluted earnings per share ("Diluted EPS") gives effect to 
all dilutive potential common shares outstanding during a period. In 
computing Diluted EPS, the treasury stock method is used in determining the 
number of shares assumed to be purchased from the conversion of common stock 
equivalents.

Because their effects are anti-dilutive, net loss per share for the years 
ended December 31, 1996, 1997 and 1998 does not include the effect of 1) 
52,230, 73,731 and 168,426, respectively, of stock options outstanding 
related to the 1993 and 1997 Stock Option Plans with a weighted average 
exercise price of $47.34, $18.87 and $11.95, respectively; 2) 137,139, 
118,768 and 118,442, respectively, of stock options outstanding related to 
the Bell Options with a weighted average exercise price of $15.51, $13.22 and 
$13.25, respectively; and 3) 52,951, 1,471,751 and 1,471,751, respectively, 
of warrants to purchase outstanding shares of Class A Common Stock with 
exercise prices ranging from $ 25.00 to $48.35 per share.

NOTE 4 -- DETAILS OF CERTAIN FINANCIAL STATEMENT COMPONENTS (IN THOUSANDS)



                                                                           DECEMBER 31,
                                                                       --------------------
                                                                         1997         1998
                                                                       -------      -------
                                                                              
PREPAID EXPENSES AND OTHER ASSETS:
   Advances to vendors..........................................       $   133      $   104
   Prepaid insurance ...........................................            63           32
                                                                       -------      -------
                                                                       $   196      $   136
                                                                       -------      -------
                                                                       -------      -------
PROPERTY AND EQUIPMENT:
   Equipment....................................................       $   767      $ 1,000
   Computer equipment...........................................           596          663
   Leasehold improvements.......................................           214          225
   Production tooling...........................................           142          330
                                                                       -------      -------
                                                                         1,719        2,218
Less: accumulated depreciation and amortization.................        (1,074)      (1,656)
                                                                       -------      -------
                                                                       $   645      $   562
                                                                       -------      -------
                                                                       -------      -------
ACCRUED LIABILITIES:
   Accrued salaries.............................................       $   171      $   201
   Accrued vacation.............................................           124          171
   Other accrued liabilities....................................            55          113
                                                                       -------      -------
                                                                       $   350      $   485
                                                                       -------      -------
                                                                       -------      -------



NOTE 5 -- INCOME TAXES

There are no assets or liabilities for income taxes, nor income tax expense 
included in the financial statements because the Company has losses since 
inception for both book and tax purposes. As of December 31, 1998, the 
Company has net operating loss carry forwards for federal and state purposes 
of $31,791,000 and $14,737,000 respectively, and has generated 

                                       F-9



tax credits from certain research and development activities of $522,000 and 
$356,000 for federal and state purposes, respectively. Federal net operating 
loss carry forwards and tax credits expire from 2008 through 2012 and state 
net operating loss carry forwards expire from 1999 through 2002. The use of 
such net operating loss carry forwards would be limited in the event of a 
change in control of the Company. In 1993, the Company elected to be taxed as 
a C corporation for both federal and state income tax purposes. Prior to that 
time, the Company was not subject to federal taxation and was subject to 
state taxation at a reduced rate (2.5%).

Temporary differences between the financial statement and tax bases of assets 
and liabilities are primarily attributable to net operating loss and tax 
credit carry forwards, depreciation, deferred revenue and accrued compensated 
absences. A valuation allowance of $12,610,000 has been provided for the 
entire amount of the deferred tax .

NOTE 6 -- EXTRAORDINARY LOSS

In connection with the repayment of debt financing obtained in 1996, the 
Company recorded a non-cash charge in 1997 of $340,000 resulting from the 
elimination of the remaining unamortized portion of the deferred debt 
issuance costs.

NOTE 7 -- COMMON STOCK

The Class A and Class B Common Stock are substantially the same on a 
share-for-share basis, except that holders of outstanding shares of Class B 
Common Stock will be entitled to receive dividends and distributions upon 
liquidation at a per share rate equal to five percent of the per share rate 
received by holders of outstanding shares of Class A Common Stock. The Class 
B Common Stock is neither transferable nor convertible and is subject to 
cancellation under certain circumstances.

FOLLOW-ON PUBLIC OFFERING OF CLASS A COMMON STOCK AND CLASS A WARRANTS

On February 18, 1997, the Company completed a public offering of 17,000 units 
(the "Units"), each consisting of 56 shares of Class A Common Stock and 56 
Class A Warrants to purchase, at $25.00 per share, an equal number of Class A 
Common Stock, resulting in the issuance of 952,000 shares of Class A Common 
Stock and 952,000 Class A Warrants. In addition, on March 7, 1997, the 
underwriter exercised an option to purchase an additional 2,550 Units or 
142,800 shares of Class A Common Stock and 142,800 Class A Warrants to cover 
over allotments. Proceeds to the Company, net of expenses, were approximately 
$17,445,000. Fees to the underwriter included an option until February 12, 
2002, to purchase 340 Units ( the "Unit Purchase Option") at 145% of the 
price to the public. The Unit Purchase Option is not exercisable by the 
underwriter until February 12, 2000.

ESCROW AGREEMENT

Prior to the effective date of the June 1993 initial public offering of the 
Company's common stock, 600,000 shares of the Company's Class A Common Stock 
("Escrowed Contingent Shares") were deposited into escrow by the then 
existing shareholders in proportion to their then current holdings. These 
shares are not transferable (but may be voted) and will be released from 
escrow in the event the Company attains certain goals including prescribed 
earnings levels (which have been adjusted for the December 29, 1995 private 
placement and for the February 1997 follow-on public offering) during the 
period through December 31, 1998.

The Company did not achieve the goals and, as such, on April 30, 1999, all 
shares held in Escrow will automatically be exchanged for shares of Class B 
Common Stock, which will then be released from Escrow.

NOTE 8 -- STOCK WARRANTS

In connection with the Company's June 1993 initial public offering of its 
common stock, the Company issued to the underwriters warrants to purchase 
through June 9, 1998, 40,951 shares of Class A Common Stock at $48.35 per, 
share as adjusted for anti-dilution provisions in the warrant agreements as a 
result of the December 29, 1995 private placement of Common Stock and the 
February 7, 1997 Follow-on Public Offering. The Company issued to third 
parties warrants to purchase 12,000 shares of Class A Common Stock at $51.25 
per share as a financial advisory fee in connection with the private 
placement completed on December 29, 1995. These warrants expire on December 
28, 2000. None of the warrants have been exercised as of December 31, 1998.

In connection with debt financing obtained in 1996 and the follow-on public 
offering completed in 1997 (Note 7), the 

                                       F-10



Company has warrants outstanding to issue 324,000 and 1,094,800 shares of 
Class A Common Stock, respectively. Each Class A Warrant entitles the 
registered holder thereof to purchase, at any time until February 12, 2002, 
one share of the Company's Class A Common Stock at an exercise price of 
$25.00, subject to adjustment. Commencing February 12, 1998, the Company may, 
upon 30 days' written notice, redeem each Class A Warrant in exchange for 
$.25 per Class A Warrant, provided that before any such redemption, the 
closing bid price of the Class A Common Stock as reported by the Nasdaq 
SmallCap Market or the closing bid price on any national exchange (if the 
Company's Class A Common Stock is listed thereon) shall have, for 30 
consecutive days ending within 15 days of the date of the notice of 
redemption, averaged in excess of $43.75 (subject to adjustment in the event 
of any stock splits or other similar events). As of December 31, 1998, the 
Company has not exercised this option and none of these warrants have been 
exercised.

NOTE 9 -- STOCK OPTIONS

1993 AND 1997 STOCK OPTION PLANS

Under the Company's 1997 and 1993 Stock Option Plans (the "Plans"), as 
amended in June 1995, 150,000 and 110,000 shares, respectively of the 
Company's Class A Common Stock are reserved for issuance, pursuant to which 
officers and employees of the Company as well as other persons who render 
services to or are otherwise associated with the Company are eligible to 
receive qualified ("incentive") and/or non-qualified stock options.

The Plans, which expire in April 2007 and 2003, respectively, are 
administered by the Board of Directors or a stock option committee designated 
by the Board of Directors. The selection of participants, allotment of 
shares, determination of price and other conditions are determined by the 
Board of Directors or stock option committee at its sole discretion, in order 
to attract and retain personnel instrumental to the success of the Company. 
Incentive stock options granted under both Plans are exercisable for a period 
of up to 10 years from the date of grant at an exercise price which is not 
less than the fair market value of the Common Stock on the date of the grant, 
except that the term of an incentive stock option granted under the Plans to 
a shareholder owning more than 10% of the voting power of the Company on the 
date of grant may not exceed five years and its exercise price may not be 
less than 110% of the fair market value of the Common Stock on the date of 
the grant.

OPTIONS GRANTED BY PRINCIPAL SHAREHOLDER ("BELL OPTIONS")

Dr. Lon E. Bell, the chairman and principal shareholder of the Company, has 
granted options to purchase shares of his Class A Common Stock, 75% of which 
were Escrowed Contingent Shares. The holder of these options could exercise 
the portions of his options related to Escrowed Contingent Shares only upon 
release of these shares from escrow as Class A Common Stock. The option 
holder had no right to purchase Class B Common Stock should such shares have 
been released. Accordingly, no such shares are available for purchase by the 
holder of the option (Note 7).

The following table summarizes stock option activity:



                                                   1993 AND 1997 STOCK OPTION PLANS            BELL OPTIONS
                                                   --------------------------------            ------------
                                                                    WEIGHTED                          WEIGHTED
                                                                    AVERAGE                            AVERAGE
                                                       NUMBER    EXERCISE PRICE          NUMBER     EXERCISE PRICE
                                                      --------   --------------         --------    --------------
                                                                                        
Outstanding at December 31, 1995................       62,998       $ 46.60              163,571        $ 14.70
Granted.........................................        6,980         51.80                2,500          51.90
Canceled........................................      (12,813)        52.90              (13,932)         27.00
Exercised.......................................       (4,000)        40.00              (16,753)          5.75
                                                      -------       -------              -------        -------
Outstanding at December 31, 1996................       53,165         47.20              135,386          12.00
Granted.........................................      115,880         17.50                    -              -
Canceled........................................      (53,408)        46.10              (13,305)         33.45
Exercised.......................................            -             -               (2,313)          5.75
                                                      -------       -------              -------        -------
Outstanding at December 31, 1997................      115,637         18.45              119,768          13.55
Granted.........................................      120,995          6.15                    -              -
Canceled........................................      (33,462)        13.15               (1,346)          5.75
Exercised.......................................            -                                  -              -
                                                      -------       -------              -------        -------
Outstanding at December 31, 1998................      203,170       $ 11.95              118,422        $ 13.25
                                                      -------       -------              -------        -------
                                                      -------       -------              -------        -------



The following table summarizes information concerning currently outstanding 
and exercisable stock options for the 1993 and 1997 Stock Option Plans as of 
December 31, 1998:

                                       F-11






                                                                         OPTIONS EXERCISABLE AT
                         OPTIONS OUTSTANDING AT DECEMBER 31, 1998           DECEMBER 31, 1998
                      ----------------------------------------------    -------------------------
                                                           WEIGHTED-                     WEIGHTED-
                                      WEIGHTED-AVERAGE      AVERAGE                       AVERAGE
RANGE OF EXERCISE       NUMBER            REMAINING        EXERCISE        NUMBER        EXERCISE 
    PRICES            OUTSTANDING     CONTRACTUAL LIFE      PRICE       EXERCISABLE       PRICE
- -----------------     -----------     ----------------     --------     ------------     --------
                                                                          
  $3.05 - 6.50          74,220              9.4            $  3.60               -       $     -
  11.40 - 18.15        114,000              8.7              15.95          65,998         17.10
  20.15 - 21.90         14,123              8.5              21.10           8,255         20.95
  48.75 - 56.25            827              6.5              54.76             720         54.58
                       -------                                              ------
                       203,170                                              74,973
                       -------                                              ------
                       -------                                              ------



The following table summarizes information concerning currently outstanding and
exercisable stock options for the Bell Option Plan as of December 31, 1998:




                                                                         OPTIONS EXERCISABLE AT
                         OPTIONS OUTSTANDING AT DECEMBER 31, 1998           DECEMBER 31, 1998
                      ----------------------------------------------    -------------------------
                                                           WEIGHTED-                     WEIGHTED-
                                      WEIGHTED-AVERAGE      AVERAGE                       AVERAGE
RANGE OF EXERCISE       NUMBER            REMAINING        EXERCISE        NUMBER        EXERCISE 
    PRICES            OUTSTANDING     CONTRACTUAL LIFE      PRICE       EXERCISABLE       PRICE
- -----------------     -----------     ----------------     --------     ------------     --------
                                                                          
      $5.75              81,822             4.2            $  5.75           9,017       $  5.75
      30.00              36,600             4.4              30.00           2,337         30.00
                        -------                                             ------
                        118,422                                             11,354
                        -------                                             ------
                        -------                                             ------



The Company accounts for these plans under APB Opinion No. 25. Had 
compensation expense for these plans been determined consistent with SFAS 
123, the Company's net loss and net loss per share would have been increased 
to the pro forma amounts in the following table. The pro forma compensation 
costs may not be representative of that to be expected in future years.



                                            YEARS ENDED DECEMBER 31,
                                          ----------------------------
                                             1997             1998
                                          ----------       ----------
                                            (IN THOUSANDS, EXCEPT 
                                                PER SHARE DATA)
                                                     
Net Loss
   As reported.........................   $  (5,417)       $  (7,704)
   Pro Forma...........................      (6,136)          (7,929)
Basic and diluted loss per share

   As reported.........................   $   (3.08)       $   (4.03)
   Pro Forma...........................       (3.49)           (4.15)



The fair value of each stock option grant has been estimated pursuant to SFAS
123 on the date of grant using the Black-Scholes option-pricing model with the
following weighted average assumptions:



                                        1993 AND 1997 STOCK OPTION PLANS           BELL OPTION PLAN
                                        ---------------------------------     ---------------------------
                                            1997                 1998            1997            1998
                                        ------------         ------------     ------------   ------------
                                                                                 
Risk free interest rates...............           6%                 6%               6%             6%
Expected dividend yield................         none               none             none           none
Expected lives.........................     4.3 yrs.           4.3 yrs.         4.3 yrs.       4.3 yrs.
Expected volatility....................          55%                60%              55%            60%



The weighted average grant date fair values of options granted under the 1993 
Stock Option Plan during 1997 and 1998 were $17.90 and $6.26, respectively. 
No options were granted under the Bell Option Plan during 1997 and 1998.

NOTE 10 -- LICENSES

CLIMATE CONTROL SEAT SYSTEM. In 1992, the Company obtained the worldwide 
license to manufacture and sell technology for a Climate Control Seat system 
to individual automotive OEMs. Under the terms of the license agreement, 
royalties are 

                                       F-12



payable based on cumulative net sales and do not require minimum payments. 
The Company has recorded royalty expense under this license agreement of 
$8,500, $18,000 and $43,000 in 1996, 1997 and 1998, respectively.

RADAR SYSTEM. In January 1994, the Company entered into a license agreement 
for exclusive rights in certain automotive applications to certain radar 
technology. Royalties are required to be paid based on cumulative net sales 
and are subject to minimum annual royalties beginning in 1995. The minimum 
royalty payments for 1996 and 1997 were $100,000 and $150,000 respectively, 
and were expensed as Research and Development. The exclusivity portion of 
this Licensing Agreement was not renewed in 1998 and minimum royalty payments 
are no longer required.

NOTE 11 -- MAJOR CONTRACTS

In December 1994, the Company entered into contracts with two Asian 
manufacturing companies to produce approximately 50 aluminum chassis 
passenger electric vehicle systems. These contracts, together with 1995 
additions, were valued at approximately $9,600,000 and were completed in 
fiscal year 1997. The Company received $4,193,000 and $1,487,000 in 1996 and 
1997, respectively. For the years ended December 31, 1996 and 1997, the 
Company recognized revenue of $5,328,000 and $145,000, respectively, from 
this contract.

NOTE 12 -- GRANTS

Grant funding received by the Company are essentially cost sharing 
arrangements whereby the Company obtains reimbursement from the funding 
source for a portion of direct costs and reimbursable administrative expenses 
incurred in managing specific programs related to the technologies utilized 
in the Company's products. The Company is obligated to provide specified 
services and to undertake specified activities under its arrangement with the 
funding sources for these programs.

Grant funding received in 1996 and 1997 of $840,000 and $389,000 
respectively, related to CALSTART, Inc., a not-for-profit consortium of 
public and private entities (Note 14) which was organized to support programs 
designed to promote the development of advanced transportation including the 
advancement of electric vehicles. The Company did not receive any grant 
funding in 1998.

NOTE 13 -- COMMITMENTS AND CONTINGENCIES

The Company leases its facility in Irwindale, California for $20,000 per 
month under an agreement which expires December 31, 2002. Rent expense under 
all of the Company's operating leases was $595,000, $415,000 and $266,000 for 
1996, 1997 and 1998, respectively. Future minimum lease payments under this 
lease are $240,000 in 1999, 2000, 2001 and 2002.

The Company has entered into certain office and computer equipment leases 
under long-term lease arrangements which are reported as capital leases. The 
terms of the leases range from three to five years with interest rates 
ranging from 11.8% to 19.7%. Future minimum lease payments under these 
capital leases are $45,000, $13,000, $6,000 and $6,000, respectively, for 
years ending December 31, 1999, 2000, 2001 and 2002 of which $6,000 
represents total interest to be paid and $39,000 was included in accounts 
payable at December 31, 1998.

NOTE 14 -- RELATED PARTY TRANSACTIONS

Dr. Bell, Chairman of the Board and the principal shareholder of the Company, 
co-founded CALSTART (Note 12) in 1992, served as its interim President, and 
for the last five years has served on CALSTART's Board of Directors and is a 
member of its Executive Committee. Included in accounts receivable at 
December 31, 1997 and 1998 was a receivable owed to the Company from CALSTART 
of $153,000 and $41,000, respectively, relating primarily to amounts withheld 
from payments made by CALSTART under several grant programs. In addition, in 
December 1995, the Company signed a thirteen-month lease with CALSTART for a 
24,000 square foot manufacturing and office facility located in Alameda, 
California for an advance payment of $450,000 and $11,000 per month. The 
lease expired in 1997.

The Company leases its current facilities from a partnership which is 
controlled by Dr. Bell. The Company believes that the terms of the lease are 
at least as favorable as those that could be obtained from other lessors.

                                       F-13



NOTE 15 -- JOINT VENTURE AGREEMENT

On July 24, 1997, the Company entered into a joint venture agreement with 
Yazaki Corporation ("Yazaki") to develop and market the Company's Interactive 
Voice System (IVS-TM-), a voice activated navigation system. Under the terms 
of the agreement, the Company received $1,800,000 in cash and a note 
receivable for $1,000,000 in consideration for the net assets related to 
Amerigon's voice interactive technology totaling $89,000. In addition, the 
Company incurred costs of $348,000 associated with the sale. In 1998, the 
Company received approximately $971,000 in payment of the remaining 
$1,000,000 noted above. The $971,000 is net of approximately $29,000 of prior 
year navigation system related expenses owed by Amerigon to IVS.

On December 16, 1998, the Company entered into a Letter Agreement with a 
group of Companies controlled by Sudaishan K. Maini (the "Maini Group") to 
develop and market the Company's electric vehicle systems ("EV"). Under the 
terms of the Letter Agreement, the Company would receive a 25% interest in a 
company to be formed as well as received royalties in exchange for 
contribution of certain assets and technology to the joint venture. The 
Company's net book value of such assets was nil at December 31, 1998. This 
agreement will be assigned to a subsidiary to be formed by the Company 
(Note 17).

NOTE 16 -- SEGMENT REPORTING

In 1998, the Company adopted SFAS 131, "Disclosures about Segments of an 
Enterprise and Related Information" which requires the Company to disclose 
certain segment information used by management for making operating decisions 
and assessing the performance of the Company. Essentially, management 
evaluates the performance of its segments based primarily on operating 
results before depreciation and selling, general and administrative costs. 
Such accounting policies used are the same as those described in Note 3.

The Company's reportable segments are as follows:

- -    CLIMATE CONTROL SEATS (CCS) - variable temperature seat climate control
     system designed to improve the temperature comfort of automobile
     passengers.

- -    RADAR - radar-based sensing system that detects objects that reflects radar
     signals near the automobile and provides an audible or visual signal as the
     driver approaches the object.

- -    ELECTRIC VEHICLE SYSTEMS (EV) - design and development of electric vehicles
     and related components. The Company is currently in the process of
     formalizing a joint venture for its electric vehicles systems (Note 15).

- -    INTERACTIVE VOICE NAVIGATION (IVS-TM-) - voice recognition technology
     incorporating proprietary features and computer systems which allows the
     driver to receive directions to their destination while driving their
     vehicle. In 1997, the Company entered into a joint venture agreement
     whereby all related assets were sold (Note 15).

The table below presents information about the reported revenues and 
operating loss of Amerigon for the years ended December 31, 1998, 1997 and 
1996 (in thousands). Asset information by reportable segment is not reported, 
since management does not produce such information.



                                                                        RECONCILING         AS
                          CCS         RADAR       EV        IVS-TM-        ITEMS         REPORTED
                        -------      -------   --------     -------     -----------     ---------
                                                                      
    
1998
   Revenue              $   396      $  329    $    45      $     -      $        -     $    770
   Operating loss        (2,844)       (455)      (545)           -       (1)(4,098)      (7,942)

1997
   Revenue                  451         135        611          111               -        1,308
   Operating loss          (978)       (702)    (1,194)        (501)      (1)(4,471)      (7,846)

1996
                            
   Revenue                  258         311      6,168          710                        7,447
    Operating loss          (17)       (378)    (4,904)      (1,125)      (1)(3,410)      (9,834)



 (1)     Represents selling, general and administrative costs of $3,053,000,
         $4,309,000 and $3,516,000, respectively, including 

                                       F-14



         depreciation expense of $357,000, $162,000 and $482,000, respectively,
         for years ended December 31, 1998, 1997 and 1996.

Revenue information by geographic area (in thousands):



                                                     YEARS ENDED DECEMBER 31,
                                    ----------------------------------------------------------
                                          1996                 1997                 1998
                                    -----------------     ----------------    -----------------
                                                                     
United States - Commercial             $   598              $    211             $     58
United States - Government               1,700                   416                  103
Asia                                     5,114                   556                  461
Europe                                      35                   125                  148
                                    -----------------     ----------------    -----------------
Total Revenues                         $ 7,447              $  1,308             $    770
                                    -----------------     ----------------    -----------------
                                    -----------------     ----------------    -----------------


In 1998, three customers, two foreign (CCS) and one government (Radar) 
represented 12%, 30% and 13% of the Company's sales. In 1997, three 
customers, one foreign and one government (EV) and one foreign (CCS/Radar) 
represented 11%, 30% and 19% of the Company's sales. In 1996, two customers, 
one foreign and one government (EV) represented 63% and 15% of the Company's 
sales.

NOTE 17--SUBSEQUENT EVENTS

On January 28, 1999, the Company effected a 1 for 5 reverse stock split. 
Share information for all periods has been retroactively adjusted to reflect 
the split.

On March 23, 1999, the Company's Board of Directors agreed to form a 
subsidiary to hold the Company's electric vehicle systems ("EV") operations 
(Note 15). Pursuant to discussions held among the Company's Board of 
Directors and Dr. Bell, Chairman of the Board and a significant shareholder 
of the Company, the Company agreed to sell to Dr. Bell a 15% interest in the 
EV subsidiary for $88,000. The Board of Directors also approved a proposal to 
sell to Dr. Bell its remaining 85% interest in the EV subsidiary in exchange 
for all of his Class B Common Stock (to be released from escrow April 30, 
1999) in order to satisfy a condition of the proposed financing described 
below. The Class B Common Stock will be cancelled. The sale of the remaining 
interest in the EV subsidiary is subject to shareholder approval. The net 
assets of the EV operation were nil at December 31, 1998.

On March 23, 1999, the Board of Directors approved a proposed financing 
transaction (the "Financing") with an investor group. Under the terms of the 
Financing the Company will issue 9,000 shares of Series A Preferred Stock and 
Warrants to purchase up to 1,651,180 shares of Class A Common Stock in 
exchange for $9,000,000. The Series A Preferred Stock will initially be 
convertible into 5,373,134 shares of Class A Common Stock. The Financing is 
subject to shareholder approval. It is anticipated that an affiliate of the 
investor group will extend up to $1,200,000 in loans bearing interest at 10% 
per annum which is due and payable upon the earlier of the closing of the 
Financing or September 30, 1999. The affiliate will also receive warrants to 
purchase 300,000 shares of Class A Common Stock.

                                       F-15



                                           AMERIGON INCORPORATED
                               SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS
                           FOR THE YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998
                                              (IN THOUSANDS)



                                            
                                               BALANCE AT      CHARGED TO     CHARGED TO     DEDUCTIONS                   
                                               BEGINNING OF    COSTS AND        OTHER           FROM         BALANCE AT END 
                  DESCRIPTION                     PERIOD        EXPENSES       ACCOUNTS       RESERVES          OF PERIOD
                  -----------                  ------------    ----------     ------------   ------------   ---------------
                                                                                               
ALLOWANCE FOR DOUBTFUL ACCOUNTS

Year Ended December 31, 1996...............      $   100         $    80         $     -       $   (100)         $     80
Year Ended December 31, 1997 ..............           80               -               -               -               80
Year Ended December 31, 1998...............           80              27               -             (6)              101

ALLOWANCE FOR DEFERRED INCOME TAX ASSETS

Year Ended December 31,1996................        3,919           3,242               -              -             7,161
Year Ended December 31, 1997 ..............        7,161           2,118               -              -             9,279
Year Ended December 31,1998................        9,279           2,726               -              -            12,005




                                       F-16


                                   SIGNATURES

     Pursuant to the requirements of Section 13 or 15(d) of the Securities 
Exchange Act of 1934, the registrant has duly caused this report to be signed 
on its behalf by the undersigned, thereunto duly authorized.


                              AMERIGON INCORPORATED

                              By:  /s/ Lon E. Bell

                                 ------------------
                                 Lon E. Bell, Ph.D.

                              CHIEF EXECUTIVE OFFICER
                                         AND
                               CHAIRMAN OF THE BOARD

                                    March 29, 1999
                                --------------------
                                        (Date)

     Pursuant to the requirements of the Securities Exchange Act of 1934, 
this report has been signed below by the following persons on behalf of the 
registrant in the capacities and on the dates indicated.



                     SIGNATURE                                               CAPACITY                                  DATE
                     ---------                                               --------                                  ----
                                                                                                           
            /s/ Lon E. Bell                         Chief Executive Officer and Chairman of the Board            March 29, 1999
           -----------------------------

                Lon E. Bell, Ph. D.


            /s/ Richard A. Weisbart                 President and Chief Operating Officer                        March 29, 1999
           -----------------------------

                Richard A. Weisbart

                                                     
              /s/ Roy A. Anderson                    Director                                                    March 29, 1999
           -----------------------------

                  Roy A. Anderson

                                                     
               /s/ John W. Clark                     Director                                                    March 29, 1999
           -----------------------------

                   John W. Clark

                                                     
             /s/ Michael R. Peevey                   Director                                                    March 29, 1999
           -----------------------------
                 Michael R. Peevey


               /s/ Scott O. Davis                    Chief Financial Officer and Secretary                       March 29, 1999
           -----------------------------
                   Scott O. Davis